From owner-ageing@net.bio.net Fri Apr 01 23:00:00 1994
Path: biosci!agate!howland.reston.ans.net!noc.near.net!news.delphi.com!usenet
From: GREGORY C.O'KELLY <gokelly@delphi.com>
Newsgroups: bionet.molbio.ageing
Subject: molecular biology, cellular senescence,and the lessons of physics
Date: Sat, 2 Apr 94 02:56:47 -0500
Organization: Delphi (info@delphi.com email, 800-695-4005 voice)
Lines: 15
Message-ID: <R2-s51v.gokelly@delphi.com>
NNTP-Posting-Host: bos1f.delphi.com

	The following message is an abstract of a paper that deals with the
history of biological thought with regard to the nature of bioelectricity and
nerve impulse propagation.  Although the paper focuses on neurophysiology, the
lessons contained therein are directly relevant to understanding the nature of
inter and intracellular chemistry, and allusions are made to these issues in
the paper.  The point is made that the 'energy' produced by mitochondria and
necessary for cellular chemical activity is nothing more than chemical energy
wich is known as negative electrical charge.  The failure of orthodox medicine
to appreciate the lessons of quantum electrodynamics in this regard is ex-
tensively detailed.  The consequences for the study of cell ageing are signif-
icant.  By bombarding a cell with electrical charge it is energized as if by
powerfully functioning mitochondria.  It is not enough to immerse the cell in
a medium conducive to its perpetuation and study how it runs down in order to
gain an idea of the cell's lifespan.  The paper alludes too the nature of the
ageing process of the organism itself in terms of its cellular chemistry.

From owner-ageing@net.bio.net Sun Apr 03 23:00:00 1994
Path: biosci!agate!ihnp4.ucsd.edu!usc!howland.reston.ans.net!noc.near.net!news.delphi.com!usenet
From: GREGORY C.O'KELLY <gokelly@delphi.com>
Newsgroups: bionet.molbio.ageing
Subject: Re: molecular biology, cellular senescence,and the lessons of ph
Date: Sun, 3 Apr 94 21:04:44 -0500
Organization: Delphi (info@delphi.com email, 800-695-4005 voice)
Lines: 120
Message-ID: <ho-NZ30.gokelly@delphi.com>
References: <R2-s51v.gokelly@delphi.com> <RU+tBJ-.gokelly@delphi.com>
NNTP-Posting-Host: delphi.com
X-To: GREGORY C.O'KELLY <gokelly@delphi.com>

	I present an abstract of a paper, "Biology, Bioelectricity, and 
the Nervous System", which I would like to have considered by 
others of a scientific bent.  The paper is at once challenging and soporific.  It is challenging because the material is quite cross 
disciplinary, and involves the history and the philosophy of science 
as well as knowledge about paleoanthropology, medicine, 
evolutionary theory, and physics.  It is soporific because it is often 
technical or esoteric, so that few will grasp its entirety, and many 
will set it aside unfinished.
	The paper begins with a discussion of the attempt by 
biologists, most notably Ernst Mayr of Harvard, to qualify biology as 
scientific by specifying what qualifies as science.  The paper points 
out that even by this specification biology does not qualify as 
science, and that the Mayrian notion that biology has escaped the 
millstone of Descartes is incorrect.  The paper points out how Mayr's 
own biological prejudices against the notion of discontinuity in 
vertebrate and mammalian speciation flow from his desire to 
maintain the barrier between biology and physics.  This issue is 
returned to in the epilogue.  It is one of the theses of this paper that Descartes and Newton still exercise a strong influence over 
biological thought, especially in the idea that only the first of the 
four fundamental forces of nature (gravity, electromagnetism, the 
strong force, the weak force) is considered pertinent to biology, that 
creatures are thought of as mechanisms, and that is what 
biochemists look for.  It is pointed out that this outlook is 
especially characteristic of thinking about the nervous system, the 
lack of a model of the functional organization of that system still 
being what Mayr calls a bottleneck in biological thought.
	In the first part of the paper, NEUROLOGY, ELECTRICITY AND
THE NATURE OF NERVE IMPULSE PROPAGATION, a history of medical 
electricity is presented simultaneously with a discussion of how the 
thinking of physicists was changing with regard to the nature of 
electricity.  It is pointed out that most of the conclusions with regard to the use of electrical stimulation to simulate nervous 
functioning were made before the electron was even hypothesized, 
the rest were made before the nature of the electron was understood 
by physicists.  In this section is a discussion of the galvanic/faradic 
distinction - that is, the difference between AC and DC in terms of 
electron behavior, and how medicine failed to grasp the significance 
of polarity of electrical charge on chemical reactions, especially 
those involving neurotransmitters.
	The next section, VIEWS OF NERVOUS SYSTEM FUNCTIONING, 
starts with a discussion of how medical/neurological views of 
nervous functioning and electricity solidified in 1870, long before 
the physicists understood the nature of electricity.  These ideas 
were institutionalized in the name of Sir Charles Sherrington, the 
father of modern neuro-physiology, in the first part of this century.  It is stated that even Peter Medawar observes as recently as 1983 
that neurology can do nothing more than it could do 100 years 
earlier.  Thorough discussion of the role of the ignorance of 
electricity's functioning upon 19th century speculation about 
nervous functioning is presented.  It is shown how the structure of 
neuroanatomy was misinterpreted in its functioning prior to and in 
the first part of the 20th century because the working of electricity 
was not yet even understood by physicists, even though it was 
already being used by engineers.  It is pointed out in this section 
that traditional explanations of nervous functioning were never 
questioned, and were even awarded a Nobel Prize in 1963 for a bit of 
work by Sir John Eccles, Hodgkin and Huxley that is an affront to all 
philosophers of science and physicists, but is still taught as 
doctrine today.   Neurologists insist on retaining a view of the nervous system that leaves it in an impoverished state with regard 
to possibly being an information processing system, and 
neuroscientists no longer question sciosophistic explanations of 
nerve impulse propagation that leave their discipline the most inept 
branch of clinical medicine.	In the next section, THE FUNCTIONING OF 
THE NERVOUS SYSTEM BASED UPON AN EXAMINATION OF ITS 
STRUCTURE AND CONSIDERATION OF THE NATURE OF BIOELECTRICITY, 
the effects on organic molecules and the origins of life, and on extra 
and intracellular chemistry of electrical charge, are detailed.   This 
is especially crucial for understanding motor functioning, and for 
seeing 'behavior' as the result of the movement of electrical charge, 
not the intervention of mind and consciousness in a dualistic world.  
For the biologists and their mechanisms, 'energy' and 'information' 
meant molecular momentum and some anthropomorphic form of cellular intelligence.  For the physicists it meant direct current and 
electrolysis.  In this section is also discussed the 
electronmicroscopic structure of muscle and how it legislates 
against Sherrington's own 'reflex activity of the spinal cord', 
reflexes being something that every neurologist knows how to check 
for, and how useless such things are for diagnosis and treatment.  In 
addition, parallels between atrophy and aging are discussed as well 
as the possibility that some paralysis resulting from CNS trauma 
are do to deterioration of the muscle and not irreversible CNS 
damage.
	In the next section, NERVOUS SYSTEM FUNCTIONING, 
COMPLEXITY, AND STIMULATION, the relation between motor activity
 and brain complexity is clearly staked out.  In addition, organism 
behavior as well as the functioning of the organism's cells are hypothesized to be dependent upon the same laws of nature, the 
movement of electrochemical energy, rather than the cells being 
electrochemical while the organism has a consciousness or some 
'vital' force within it.  With this in mind it is detailed how the CNS 
and the body may be maintained by the introduction of electrical 
charge via transcutaneous electrode, thereby preventing or curing 
chronic and degenerative illnesses and aging.
	Finally, in the epilogue it is discussed once again how Mayr's 
views of the continuity of genetic change and vertebrate speciation 
conflict not only with the fossil record (which is more supportive of 
the views of Gould and Eldridge with their 'punctuated equilibria'), 
but with a view of the nervous system which holds that nervous 
system complexity is better indicated by the number of emergent 
axons from that system, whether centrally or peripherally, than relative brain and body weights and cranial capacities.  The number 
of axons is associated with the ganglia and alpha motor neurons, 
with the addition of pairs of these due to 'systemic mutations', an 
idea expressly disdained by Mayr.  It is stated, in conclusion, that 
this approach to the nervous system is right in line with the calls of 
Gerald Edelman, Nobel Laureate and director of the Neurosciences 
Institute and chairman of the Department of Neurobiology at the 
Scripps Research Institute, calls for 'a theory of how morphology 
arises and how it is changed during evolution';  'how alterations in 
form, either in the whole animal or at microscopic levels of brain, 
evolution;  Mayr calls it 'macroevolution'.
	
	I would greatly appreciate the comments and criticisms of 
anyone who has the patience and perseverance to finish this paper 
and to ruminate over the ideas presented therein.  This is just the 
proffered foundation of a theory, an hypothesis which can overturn 
its competition from the orthodox neurological community by resort to electronmicroscopic muscle biopsies which will overrule the 
clinical manual of neuroanatomy, flawed as it is, with regard to 
spinal reflexes being posited as responsible for the spasticity and 
rigidity of the spinal injured.  I would like someday, having gotten 
this considered, to answer the 'so what?' of the issue as it relates 
to clinical application to chronic and degenerative illnesses and the 
aging process.
	For a copy of this paper binhexed please write to 
gokelly@delphi.com

From owner-ageing@net.bio.net Mon Apr 04 23:00:00 1994
Path: biosci!CSUVAX1.MURDOCH.EDU.AU!sutarno
From: sutarno@CSUVAX1.MURDOCH.EDU.AU (Sutarno)
Newsgroups: bionet.molbio.ageing
Subject: new subscriber
Date: 4 Apr 1994 20:55:04 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 9
Sender: daemon@net.bio.net
Distribution: bionet
Message-ID: <Pine.3.87.9404051156.A5084-0100000@csuvax1>
NNTP-Posting-Host: net.bio.net

 I would like to subscribe to the net. My complete name and address are:
Nano Sutarno
Vet. Biology
Vet. School
Murdoch University
WA 6150
AUSTRALIA



From owner-ageing@net.bio.net Wed Apr 06 23:00:00 1994
Path: biosci!bcm!cs.utexas.edu!swrinde!emory!news.cc.emory.edu!wzhou-sl.cc.emory.edu!wzhou
From: wzhou@emoryu1.cc.emory.edu
Newsgroups: bionet.molbio.ageing
Subject: Apoptosis and Necrosis
Date: 7 Apr 1994 14:53:10 -0400
Organization: Emory University
Lines: 7
Sender: news@emoryu1.cc.emory.edu
Message-ID: <wzhou.8.2DA45687@emoryu1.cc.emory.edu>
NNTP-Posting-Host: emoryu1.cc.emory.edu
X-Newsreader: Trumpet for Windows [Version 1.0 Rev B]

Dear Netters:  What is the single most important distinctions between these 
two kinds of cell death?  I am puzzled by the traditional classifications.   
Few days ago, I post a message asking whether apoptotic bodies would exclude 
trypan blue.  I got only one response.  Do apoptotic cells maintain their 
membrane intergrity?  

wzhou@bimcore.cc.emory.edu

From owner-ageing@net.bio.net Thu Apr 07 23:00:00 1994
Path: biosci!sjubiol.stjohns.edu!rick
From: rick@sjubiol.stjohns.edu (Richard Lockshin)
Newsgroups: bionet.molbio.ageing
Subject: apoptosis (speakers)
Date: 7 Apr 1994 20:39:58 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 9
Sender: daemon@net.bio.net
Distribution: bionet
Message-ID: <9404072226.AA20504@sjubiol.stjohns.edu>
NNTP-Posting-Host: net.bio.net

I am beginning to organize a conference on cell death (scheduled
for August, 1995).  I have a potential program in mind but, in
order to do the best job that I can, I would be interested to 
hear other's thoughts on topics or speakers.  I would appreciate
a line or two of justification for topics.  In terms of speakers,
the operative adjectives would be:  thoughtful, provocative, 
creative, insightful, analytical.  Please reply via private
email to rick@sjubiol.stjohns.edu.  I give a report later on as
appropriate.

From owner-ageing@net.bio.net Thu Apr 07 23:00:00 1994
Path: biosci!sjubiol.stjohns.edu!rick
From: rick@sjubiol.stjohns.edu (Richard Lockshin)
Newsgroups: bionet.molbio.ageing
Subject: apoptosis and necrosis
Date: 7 Apr 1994 22:50:05 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 28
Sender: daemon@net.bio.net
Distribution: bionet
Message-ID: <9404080458.AA20647@sjubiol.stjohns.edu>
NNTP-Posting-Host: net.bio.net

mzhou@bimcore.cc.emory.edu asks for the distinctions between apoptosis and 
necrosis.  start with the Tomei-Cope book (Cold Spring Harbor Press) and 
Wyllie's review 2 years ago.  Otherwise, see the review by Zakeri and 
Lockshin in the Ann NY Acad Sci edited by Franceschi C et al last year.  
Necrosis is usually described as an uncontrolled membrane-failure lysis, 
resulting in swelling and rupture of the cell and organelles and (in 
mammals) an inflammatory response.  Apoptotic cells typically shrink,
apparently retaining membrane integrity (though one or a few authors 
dispute the point) and show nuclear condensation and at least temporary
preservation of organelle structure.  there are both lysosomal and non-
lysosomal forms of controlled cell death.  the trypan blue staining is
typically for gross identification and is usually for macrophages that
are destroying these apoptotic bodies.  in vivo, apoptotic bodies exist
for very short periods (Schulte-Hermann and Bursch, about 3 years ago, 
or see the Cold Spring Harbor book for an article by Schulte-Hermann).
Apoptotic bodies can be identified by electron microscopy, H & E or
toluidine blue staining, or in situ end-labeling (tunnel technique, 
Apoptag kit (Oncor)).  Free-floating cells of reticulo-endothelial 
origin may be recognized by fluorescence-sorting techniques, looking for
DNA content < 2N (numerous authors, including Wyllie and S. Umansky).
the programmed cell death paradigm, requiring synthesis of apparently 
new proteins, is not easy to detect at present, since no unique protein
can be claimed to document apoptosis.  (proteins such as TRPM-2 and
--correction, TRPM-2, alias clusterin or SGP-2--myc, fos, or ubiquitin)
are clearly NOT "cell death proteins".  High levels of cross-linkage
may be useful but the technique is difficult.  See also Zakeri et al,
FASEB J January 93; a follow-up is coming.  If you have a specific instance
in mind, I can make a more effective suggestion.

From owner-ageing@net.bio.net Fri Apr 08 23:00:00 1994
Path: biosci!sjubiol.stjohns.edu!rick
From: rick@sjubiol.stjohns.edu (Richard Lockshin)
Newsgroups: bionet.molbio.ageing
Subject: apoptosis and necrosis
Date: 8 Apr 1994 20:39:52 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 33
Sender: daemon@net.bio.net
Distribution: bionet
Message-ID: <9404081534.AA20891@sjubiol.stjohns.edu>
NNTP-Posting-Host: net.bio.net

 
Subject: Re: apoptosis and necrosis
Newsgroups: bionet.molbio.ageing
 
Tae H. Kim tkim@reed.edu writes
 
>Regarding lysosomal and non-lysosomal PCD, I would like know if 
>these two serve different functions in regards to development 
>and physiology. I would appreciate any references that you might have concerning these two pathways(?)
>of PCD.
 
see the following:
 
Schweichel, J. U. and Merker, H. J.  (1973) The morphology
of various types of cell death in prenatal tissues.  
Teratology. 7, 253-266.
 
Clarke, P. G. H.  (1990) Developmental cell death:  Morphological diversity
and multiple mechanisms.  Anat. Embryol. 181, 195-213.
 
Beaulaton J and Lockshin RA (1982) The relation of programmed 
cell death to development and reproduction:  comparative studies
and an attempt at classification.  Int. Rev. Cytol.  29:
215-235.
 
a group of us are developing a paper to bring back to attention
these forgotten papers.  There is no particular theory, except
to note that cell debris is consumed either by intracellular
lysosomes (autophagic vacuoles) or by vacuoles in other cells
(phagocytosis).  The former is commonly seen in insects and
in tissues such as the mammary gland, but other than the
papers listed above it hasn't been well worked out.
 

From owner-ageing@net.bio.net Sun Apr 10 23:00:00 1994
Path: biosci!agate!ihnp4.ucsd.edu!swrinde!emory!news.cc.emory.edu!wzhou-sl.cc.emory.edu!wzhou
From: wzhou@emoryu1.cc.emory.edu
Newsgroups: bionet.molbio.ageing
Subject: More about Apoptosis
Date: 11 Apr 1994 13:21:37 -0400
Organization: Emory University
Lines: 33
Sender: news@emoryu1.cc.emory.edu
Message-ID: <wzhou.14.2DA9871C@emoryu1.cc.emory.edu>
NNTP-Posting-Host: emoryu1.cc.emory.edu
X-Newsreader: Trumpet for Windows [Version 1.0 Rev B]

Thank you all for your response to my previous post seeking your opinion about 
the distinctions between apoptosis and necrosis.   

I asked "Is it true that apoptotic cells maintain their membrane intergrity?"

Most people said "yes".  Some people said, specifically, that apoptotic cells 
exclude trypan blue.  But, many published papers, especially those 
demonstrating the protective effect of bcl-2, used trypan blue exclusion as a 
measurement of cell death.  Are those types of cell death really apoptotic or 
should they be considered as necrotic?

In normal intestinal cell lines, I can detect DNA fragmentation.  I call it 
spontaneous cell death and it is somehow cell density dependent.   I can see 
very few trypan blue stained cells even though I can identify and then purify 
detergent-insoulbe envelope (apoptotic bodies).  I assumed apoptotic cells 
were engulfed by neigboring cells before they lost their membrane intergrity.

In some transformed cell lines, such as HT-29, most dead cells detach from the 
monolayer.  Detached cells can be judged as apoptotic by acridine organe 
staining and are all stained well with trypan blue, even the cells maintaining 
good morphology (I assume they are in the early stage of cell death) .   I got 
beautiful DNA ladder from those cells.  

Is it possible that apoptotic cells, when not engulfed by other cells,  
can not maintain their membrane intergrity?  Also, what do you think is the 
function of apoptotic bodies?
I would appreciate your comments.


Wei Zhou
Emory University
wzhou@bimcore.cc.emory.edu


From owner-ageing@net.bio.net Mon Apr 11 23:00:00 1994
Path: biosci!sjubiol.stjohns.edu!rick
From: rick@sjubiol.stjohns.edu (Richard Lockshin)
Newsgroups: bionet.molbio.ageing
Subject: apoptosis and necrosis
Date: 11 Apr 1994 20:40:30 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 54
Sender: daemon@net.bio.net
Distribution: bionet
Message-ID: <9404111456.AA22161@sjubiol.stjohns.edu>
NNTP-Posting-Host: net.bio.net

 
To: rick@sjubiol.stjohns.edu
From: uunet!reed.edu!tkim (Tae Hoon Kim)
Subject: apoptosis and necrosis
 
Dear Dr. Lockshin,
 
>Thank you for the references. I was able to locate your article in our
>library--other two couldn't be found in my school library. The article was
>very helpful for me. It seems that "autophagic degeneration" occurs in
>plants as a form of programmed cell death.
>
>Do you suggest that there are more varied forms of necrosis and these can
>be "programmed"? My initial understanding of the term was that necrosis
>referred to accidental and "unprogrammed" death resulting from trauma or
>stress, thus making necrosis non-physiological death. Is it correct in
>stating that necrosis is a descriptive term, just as apoptosis is? If
>programmed cell death is understood as a functional term, then both
>necrosis and apoptosis can be understood as "programmed cell death" in
>certain contexts?
 
AFTER SOME TIME OF FIGHTING FOR CLEAR USE OF THE TERMS, I HAVE DECIDED
THAT THE WORLD WILL COME TO A DEFINITION OF THE TERMS WITH OR WITHOUT 
MY EFFORTS TO CONTROL IT.  PROGRAMMING IMPLIES IMMEDIATE GENETIC CONTROL
OF THE COLLAPSE, THOUGH NOT NECESSARILY THE PRODUCTION OF DEATH GENES.
I'M NOT SURE HOW A NECROTIC DEATH, WHICH IS CONSIDERED TO BE UNCONTROLLED,
WOULD FIT THIS DEFINITION, THOUGH SOME METAMORPHIC PROGRAMMED DEATHS
MAY RESULT IN OSMOTIC LYSIS.  IF THIS IS WHAT YOU MEAN, OK, BUT IT IS
VERY UNCOMMON.
 
>I have been reviewing some literature on senescence regarding cell death.
>How should I understand senenscence to mean, in terms of cell death. Some
>researchers have used the term "programmed senescence" in reference to
>plant cell death. I am still confused by these terms, senescence and
>programmed cell death. Many of older literature mention cell death in
>regards to senescence, but these obeservations of cell death seem to be in
>the context of development.
>
>It seems that even coelenterates undergo programmed cell death. I have not
>been able to locate a solid information concerning stalk cell
>different.
 
PLANTS AND LOWER INVERTEBRATES DO MANY CRAZY THINGS.  FOR INSTANCE, 
MATURATION OF COTYLEDONS MAY BE A PROGRAMMED DEATH, AND FLOWERS, IN 
THE TERMS OF PLANT PHYSIOLOGISTS, 'SENESCE', AS DOES THE WHOLE PLANT 
IN AN ANNUAL.  THERE WAS A SMALL LITERATURE A WHILE BACK ABOUT THE
DEATH OF CELLS IN COELENTERATES (HYDRA), IN WHICH CELLS FORM AT OR NEAR
THE MOUTH, GRADUALLY GET PUSHED TOWARD THE BASE OR FOOT, AND DIE AND
ARE DISCARDED THERE.  THE TERMS WERE FAIRLY CASUALLY AND SLOPPILY USED,
AND MOST OF THE WORK DIED OUT AS FUNDING FOR SUCH PROJECTS DRIED UP.
IF YOU COME ACROSS SOME REASONABLY MODERN, THOUGHTFUL WORK ON PLANTS
OR LOWER INVERTEBRATES, I'D LOVE TO KNOW ABOUT IT.
 
--richard a lockshin 

From owner-ageing@net.bio.net Mon Apr 11 23:00:00 1994
Path: biosci!agate!howland.reston.ans.net!wupost!ukma!seqanal.mi.uky.edu!mpm
From: mpm@seqanal.mi.uky.edu (Mark Mattson)
Newsgroups: bionet.molbio.ageing
Subject: Apoptotic vs. necrotic
Date: 12 Apr 1994 14:27:39 GMT
Organization: University of Kentucky, Dept. of Math Sciences
Lines: 26
Message-ID: <2oeb4r$rb0@s.ms.uky.edu>
NNTP-Posting-Host: seqanal.mi.uky.edu
X-Newsreader: TIN [version 1.1 PL9]

It seems to me that -- although they may be ultimately different in mechanism
of killing -- way too much emphasis has been placed on drawing a distinction
between the events which TRIGGER apoptotic or necrotic deaths.  I was 
particulary struck by the futility in this argument at last year's Society
for Neuroscience meeting where I saw at least half a dozen posters lined up
next to each other, alternating in their conclusions about whether glutamate
excitotoxicity triggered necrotic or apoptotic death.  It is my opinion
that the SAME THING triggers both:  FREE RADICALS.  Obviously, free radicals
can cause the kind of membrane damage characteristic of necrosis, and more
and more evidence suggests that free radicals can trigger apoptosis.  Ex:
bcl-2 seems to prevent apoptosis by antagonizing a radical-evoked event;
several labs suggest that tumor necrosis factors (which, despite their
name, can trigger apoptosis) use reactive oxygen species in their signal
transduction pathways.  To me, the distinction seems to be a quantitative one:
if free radicals are generated in large amounts, membranes are rapidly 
damaged; if the levels of oxidation are lower, some program (perhaps, genetic 
in nature) is activated which kills the cell more slowly.  This is consistent
with the first descriptions of apoptosis in the liver, where it was caused 
by the same insult as the coincident necrosis -- the necrosis was in the 
center of the lesion and the apoptosis was on the periphery.  One can easily
imagine that this spatial delineation was caused by the decreasing concen-
trations of radicals as they diffused concentrically from the center of the
lesion.

Steven W. Barger, Ph.D.
Sanders-Brown Center on Aging

From owner-ageing@net.bio.net Tue Apr 12 23:00:00 1994
Path: biosci!sjubiol.stjohns.edu!rick
From: rick@sjubiol.stjohns.edu (Richard Lockshin)
Newsgroups: bionet.molbio.ageing
Subject: More about apoptosis
Date: 12 Apr 1994 20:40:18 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 44
Sender: daemon@net.bio.net
Distribution: bionet
Message-ID: <9404121634.AA22576@sjubiol.stjohns.edu>
NNTP-Posting-Host: net.bio.net

To: ageing@net.bio.net
From: uunet!emoryu1.cc.emory.edu!wzhou
Subject: More about Apoptosis
 
>In normal intestinal cell lines, I can detect DNA fragmentation.
>I call it spontaneous cell death and it is somehow cell density 
>dependent.   I can see very few trypan blue stained cells even
>though I can identify and then purify detergent-insoulbe envelope 
(apoptotic bodies).  I assumed apoptotic cells were engulfed by 
>neigboring cells before they lost their membrane intergrity.
 
intestinal cells are normally discarded into the lumen rather than
being phagocytosed.  I assume that you are seeing an (interesting)
reflection of this in vitro.  Also, cultured cells are not normally
phagocytosed.  This may be an artifact of the culture system.
 
>In some transformed cell lines, such as HT-29, most dead cells 
>detach from the monolayer.  Detached cells can be judged as 
>apoptotic by acridine organe staining and are all stained well >
with trypan blue, even the cells maintaining good morphology 
>(I assume they are in the early stage of cell death) .   I got
>beautiful DNA ladder from those cells.
 
that's nice to hear!
 
>Is it possible that apoptotic cells, when not engulfed by other 
>cells, can not maintain their membrane intergrity?  
 
That would appear to be reasonable.  At some point they must not
be able to keep up their function.  We have no reason to feel that
apoptotic bodies are like spores or other dormant cells, and we
know of no reversal from the collapsed state.
 
>Also, what do you think is the function of apoptotic bodies?
 
I don't know what you mean by the question.  The evolutionary sig-
nificance of apoptosis appears to be controlled, non-inflammatory
elimination of injured cells, especially in the sense that they
are potentially dangerous (carriers of viruses or toxins, or 
lytic enzymes).  The apoptotic body appears to be an encapsulated
form of the cell.
 
 
 

From owner-ageing@net.bio.net Wed Apr 13 23:00:00 1994
Path: biosci!sjubiol.stjohns.edu!rick
From: rick@sjubiol.stjohns.edu (Richard Lockshin)
Newsgroups: bionet.molbio.ageing
Subject: more on apoptosis/necrosis
Date: 13 Apr 1994 20:22:31 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 61
Sender: daemon@net.bio.net
Distribution: bionet
Message-ID: <9404131347.AA22937@sjubiol.stjohns.edu>
NNTP-Posting-Host: net.bio.net

Message  5:
From uunet!net.bio.net!BIOSCI-REQUEST Tue Apr 12 23:43:26 1994
Return-Path: <uunet!net.bio.net!BIOSCI-REQUEST>
Received: from uunet.UUCP by sjubiol.stjohns.edu (4.0/SMI-4.0)
        id AA22767; Tue, 12 Apr 94 23:43:25 EDT
Received: from net.bio.net by relay1.UU.NET with SMTP
        (5.61/UUNET-internet-primary) id AAwlhz10138; Tue, 12 Apr 94 10:53:04 -0
400
Received: (from daemon@localhost) by net.bio.net (8.6.8.1/8.6.6) id HAA18286 for
 ageing-list; Tue, 12 Apr 1994 07:28:29 -0700
Received: (from news@localhost) by net.bio.net (8.6.8.1/8.6.6) id HAA18282 for a
geing-arpanet; Tue, 12 Apr 1994 07:28:28 -0700
To: ageing@net.bio.net
From: uunet!seqanal.mi.uky.edu!mpm (Mark Mattson)
Subject: Apoptotic vs. necrotic
Date: 12 Apr 1994 14:27:39 GMT
Message-Id: <2oeb4r$rb0@s.ms.uky.edu>
Nntp-Posting-Host: seqanal.mi.uky.edu
X-Newsreader: TIN [version 1.1 PL9]
Status: R
 
It seems to me that -- although they may be ultimately different in
>mechanism of killing -- way too much emphasis has been placed on drawing
>a distinction between the events which TRIGGER apoptotic or necrotic 
>deaths.  I was particulary struck by the futility in this argument at 
>last year's Society for Neuroscience meeting where I saw at least half a dozen 
>posters lined up next to each other, alternating in their conclusions about 
>whether glutamate excitotoxicity triggered necrotic or apoptotic death.  
>It is my opinion that the SAME THING triggers both:  FREE RADICALS.  
>Obviously, free radicals can cause the kind of membrane damage characteristic 
>of necrosis, and more and more evidence suggests that free radicals can 
>trigger apoptosis.  Ex: bcl-2 seems to prevent apoptosis by antagonizing a 
>radical-evoked event; several labs suggest that tumor necrosis factors (which, 
>despite their name, can trigger apoptosis) use reactive oxygen species 
>in their signal transduction pathways.  To me, the distinction seems to be a 
>quantitative one: if free radicals are generated in large amounts, membranes 
>are rapidly damaged; if the levels of oxidation are lower, some program 
>(perhaps, genetic in nature) is activated which kills the cell more slowly.  
>This is consistent with the first descriptions of apoptosis in the liver, 
>where it was caused by the same insult as the coincident necrosis -- 
>the necrosis was in the center of the lesion and the apoptosis was on the 
>periphery.  One can easily imagine that this spatial delineation was caused 
>by the decreasing concentrations of radicals as they diffused 
>concentrically from the center of the lesion.
>
>Steven W. Barger, Ph.D.
>Sanders-Brown Center on Aging
 
you won't get an argument from me on this.  You are following pretty much
the same argument as Amedeo Columbano and Vanna Ledda-Columbano of Cagliari
(Sardinia) Italy.  They publish on hepatotoxins, usually in Am. J. Pathol.
or similar journals.  I think that the image of a lot of people is 
coalescing:  that if a cell has time to think about its injury and nurse
its wounds, it is capable of collapsing by an apoptotic means.  Otherwise,
it lyses (necrosis).  The Columbanos observed that moderate-dose hepato-
toxins would produce prompt necrosis followed later by a wave of apoptosis.
Free radicals are certainly one means of creating cell injury.  They may
not be the only way.
 
--Richard Lockshin
St. John's University

From owner-ageing@net.bio.net Wed Apr 13 23:00:00 1994
Path: biosci!ESSEX.HSC.COLORADO.EDU!deutschj
From: deutschj@ESSEX.HSC.COLORADO.EDU (John Deutsch)
Newsgroups: bionet.molbio.ageing
Subject: antioxidants
Date: 14 Apr 1994 14:55:35 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 7
Sender: daemon@net.bio.net
Distribution: bionet
Message-ID: <Pine.3.05.9404141506.B12976-9100000@essex.hsc.colorado.edu>
NNTP-Posting-Host: net.bio.net

I am measuring labile nutrient antioxidants in serum, urine and CSF.  I am
particularly interested in samples from aged or ascorbate deficient guinea
pigs.  If anyone has an interest in this area or a bank of samples
preferably stored below -70, with controls, please contact me.




From owner-ageing@net.bio.net Thu Apr 14 23:00:00 1994
Newsgroups: bionet.molbio.ageing
Path: biosci!headwall.Stanford.EDU!ames!sgiblab!swrinde!emory!europa.eng.gtefsd.com!howland.reston.ans.net!vixen.cso.uiuc.edu!uwm.edu!news.mr.med.ge.com!wind!hinz
From: hinz@wind (David Hinz W-641 548-3221 )
Subject: Aging rates/human vs. dog
Message-ID: <1994Apr14.235840.7253@mr.med.ge.com>
Sender: news@mr.med.ge.com
Nntp-Posting-Host: wind
Organization: GE Medical Systems, Magnetic Resonance
X-Newsreader: TIN [version 1.1 PL8]
Date: Thu, 14 Apr 94 23:58:40 GMT
Lines: 12

I've been wondering this for a while, and was hoping someone here
could answer this: 

Why do dogs often have cataracts when they reach the age of, say, 12 years,
but in humans it takes maybe 5 times as long?  Are the cells aging at a
different rate, and if so, why?  If we knew why, could we do something 
about affecting aging rates?

Thanks - I hope someone can answer what is probably a rather naive and
basic question.
Dave Hinz


From owner-ageing@net.bio.net Thu Apr 14 23:00:00 1994
Newsgroups: bionet.molbio.ageing
Path: biosci!bcm!cs.utexas.edu!howland.reston.ans.net!news.intercon.com!news.pipeline.com!malgudi.oar.net!sun!oucsace!ouvaxa.cats.ohiou.edu!JANAPATI
From: janapati@ouvaxa.cats.ohiou.edu
Subject: need post-doc position
Message-ID: <CoBCDG.F0F@oucsace.cs.ohiou.edu>
Sender: news@oucsace.cs.ohiou.edu (news account)
Reply-To: janapati@ouvaxa.cats.ohiou.edu
Organization: Ohio University Computing & Technology Services
Date: Fri, 15 Apr 1994 18:22:27 GMT
Lines: 2

seeking post-doctoral opportunity in the area of ageing/neurodegeneration/apoptosis. available immediately. cv will be sent. janapati@ouvaxa.cats.ohiou.edu.


From owner-ageing@net.bio.net Thu Apr 14 23:00:00 1994
Path: biosci!VTVM1.CC.VT.EDU!VERPHELD
From: VERPHELD@VTVM1.CC.VT.EDU
Newsgroups: bionet.molbio.ageing
Subject: fas gene
Date: 15 Apr 1994 14:20:27 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 10
Sender: daemon@net.bio.net
Distribution: bionet
Message-ID: <199404152120.OAA26594@net.bio.net>
NNTP-Posting-Host: net.bio.net

Autoimmune prone MRL/lpr mice have been reported to have deffective Fas genes
which would presumably alter the negative selection process in the thymus.  I
would like to know if anybody has any thoughtson why this deffective fas gene w
ould alter T cell development and yet have no effect on other developmental
processes mediatred through apoptosis.
************************************************************************
  Daniela I. Verthelyi
  Virgina Tech.
  USA
  VERPHERLD@VTVM1

From owner-ageing@net.bio.net Thu Apr 14 23:00:00 1994
Path: biosci!bcm!cs.utexas.edu!howland.reston.ans.net!news.ans.net!hp81.prod.aol.net!search01.news.aol.com!not-for-mail
From: capital100@aol.com (Capital100)
Newsgroups: bionet.molbio.ageing
Subject: Anti-aging drugs...
Date: 15 Apr 1994 16:31:07 -0400
Organization: America Online, Inc. (1-800-827-6364)
Lines: 5
Sender: news@search01.news.aol.com
Message-ID: <2omtib$jn5@search01.news.aol.com>
NNTP-Posting-Host: search01.news.aol.com

A number of people have queried me in reference to the FDA import guidlines,
and availability of anti-oxidants, anti-aging drugs, and "smart drugs" that are
not available in the United States.  There are several companies that I have
dealt with, if interested I would recommend contacting:  Life Extension
Services, 558-A Baltimore Pike, Suite 230, Bel Air, MD 21014.

From owner-ageing@net.bio.net Fri Apr 15 23:00:00 1994
Path: biosci!parc!barrnet.net!well!mjbrauer
From: mjbrauer@well.sf.ca.us (Matthew J. Brauer)
Newsgroups: bionet.molbio.ageing
Subject: Re: fas gene
Date: 16 Apr 1994 07:53:35 GMT
Organization: The Whole Earth 'Lectronic Link, Sausalito, CA
Lines: 21
Distribution: bionet
Message-ID: <2oo5hv$cp2@nkosi.well.com>
References: <199404152120.OAA26594@net.bio.net>
NNTP-Posting-Host: well.sf.ca.us
X-Newsreader: NN version 6.5.0 #1 (NOV)

VERPHELD@VTVM1.CC.VT.EDU writes:

>Autoimmune prone MRL/lpr mice have been reported to have deffective Fas genes
>which would presumably alter the negative selection process in the thymus.  I
>would like to know if anybody has any thoughtson why this deffective fas gene w
>ould alter T cell development and yet have no effect on other developmental
>processes mediatred through apoptosis.
>************************************************************************
>  Daniela I. Verthelyi
>  Virgina Tech.
>  USA
>  VERPHERLD@VTVM1

Induction of apoptosis probably proceeds through any of several pathways,
of which fas-mediated apoptosis is only one.

Many of the downstream apoptosis genes (e.g. bcl-2, bax, etc.) show
tissue-specific expression. It's conceivable that the signalling pathway
in developing lymphocytes is more finely modulated than in other tissues.

Matthew J. Brauer

From owner-ageing@net.bio.net Fri Apr 15 23:00:00 1994
Path: biosci!HAL.HAHNEMANN.EDU!springerj
From: springerj@HAL.HAHNEMANN.EDU
Newsgroups: bionet.molbio.ageing
Subject: bcl-2 cDNA
Date: 16 Apr 1994 07:25:49 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 7
Sender: daemon@net.bio.net
Distribution: bionet
Message-ID: <0097D09B.A91D7F60.15@hal.hahnemann.edu>
NNTP-Posting-Host: net.bio.net

I am interested in obtaining the cDNA for the bcl-2 gene for use in studying amy
otrophic lateral sclerosis (ALS). Please send info to my e-mail address: springe
rj@hal.hahnemann.edu. Thanks
Joe e. Springer,
Department of Neurology
Hahnemann University
Philadelphia, PA 19102

From owner-ageing@net.bio.net Sat Apr 16 23:00:00 1994
Newsgroups: bionet.molbio.ageing
Path: biosci!agate!dog.ee.lbl.gov!ihnp4.ucsd.edu!usc!howland.reston.ans.net!news.moneng.mei.com!uwm.edu!msuinfo!netnews.upenn.edu!news.drexel.edu!dunx1.ocs.drexel.edu!st93q84w
From: st93q84w@Dunx1.OCS.Drexel.Edu (David Hallowell)
Subject: CALL FOR PAPERS IN BIOLOGY
Message-ID: <CoDx3A.AA1@Dunx1.OCS.Drexel.Edu>
Organization: Drexel University
X-Newsreader: TIN [version 1.2 PL2]
Date: Sun, 17 Apr 1994 03:45:09 GMT
Lines: 37



                      ===============================
                       CALL FOR UNDERGRADUATE PAPERS
                                ----------
    [] [] [] THE DREXEL UNIVERSITY JOURNAL OF UNDERGRADUATE [] [] []
         [] [] [] [] [] [] BIOLOGICAL RESEARCH [] [] [] [] [] []


Requirements:

[] Papers are limited to topics in biology.
[] You must be an undergraduate at least assisting with the research on which
you plan to write. 
[] You must use the American Psychological Association (APA) format of
citing literature.  [see American Scientist for guide].

Due: 

All papers are due by May 5.

If possible, submit papers in MacWrite II compatible format. Submitted
materials cannot be returned.

   ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
   :::::::::::| FOR  MORE  INFORMATION  OR  TO  SUBMIT  A  PAPER |:::::::::::
   ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
        [] write Journal of Undergraduate Research at

                     The Journal of Undergraduate Research
                     Department of Bioscience and Biotechnology
                     Drexel University
                     32nd and Chestnut Streets
                     Philadelphia, Pennsylvania 19104

        [] send e-mail to martinpf@dunx1.ocs.drexel.edu
   ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

From owner-ageing@net.bio.net Sun Apr 17 23:00:00 1994
Path: biosci!agate!howland.reston.ans.net!news.intercon.com!psinntp!psinntp!psinntp!sjuvm!yprlbio
Nntp-Posting-Host: 149.68.2.20
Date: Sat, 16 Apr 1994 12:31:58 -0400
From: "LOCKSHIN, RICHARD A" <YPRLBIO@sjumusic.stjohns.edu>
Newsgroups: bionet.general,bionet.cellbiol,bionet.molbio.ageing
Subject: Re: Apoptosis vs. necrosis
Message-ID: <16APR94.13517670.0023@sjumusic.stjohns.edu>
References: <199404131655.JAA01867@net.bio.net> <1994Apr13.185159.1758@alw.nih.gov>
Sender: usenet@sjumusic.stjohns.edu
Organization: St. John's University
Lines: 48
Xref: biosci bionet.general:8637 bionet.cellbiol:456 bionet.molbio.ageing:715

In article <1994Apr13.185159.1758@alw.nih.gov> bernard@elsie.nci.nih.gov (Bernard Murray) writes:
>In article <199404131655.JAA01867@net.bio.net>, CGE@CU.NIH.GOV writes:
>> The definition from Dorland's medical Dictionary:
>>
>> Apoptosis is derived from the Greek Apo- [meaning separation
>> or derivation from] and -ptosis [silent p, meaning downward
>> displacement]. Apoptosis = a falling off.
>>
>> Dale, what is so strange sounding about apo-tosis? There are
>> many 'pt' words with a silent p - pteridine, pterygoid, Ptolemy,
>> asymptote, pteridophyte, ptarmigan, ptomaine, and every kids
>> favorite - pterodactyl.
>>
>> Graham
>
>
>Andrew Wyllie pronounces it as per the Greek derivation (silent p) and I assume
>he has some say in the matter.  However, since many people over here can't
>even pronounce his name correctly I think this is a lost cause.
> Personally, I'm no purist and enjoy the ay-POP-toh-siss (said with a
>distinct Southern drawl) that seems to be the norm around here.  Also, at the
>FEBS meeting in Dublin in 1992 another derivation of the name was put forward
>which supports the non-silent P....
>
>Spontaneously dying cell resembles Popcorn
>When encountered, flasks of dying cells are usually tossed in the bin/trash
>
>so...     A "pop"!  Toss it!
>
>(My apologies to the original author of this who had the advantage of a set
> of slides to put the point across)
>   Bernard
>
>
>Bernard Murray, Ph.D.
>bernard@elsie.nci.nih.gov (National Cancer Institute, NIH, Bethesda MD, USA)
>
>.
11
thanks for the note.  most of the discussion of apoptosis is taking
place in bionet.molbio.ageing (ageing@net.bio.net).  I was interested
in getting it going in bionet.cellbiol (cellbiol@net.bio.net) but
not too many people are interested there.  i personally would prefer
that it not be in bionet.general--it's too slow to get through it!
richard a lockshin, st. john's u (yprlbio@sjumusic.stjohns.edu for
news board type of material, or rick@sjubiol.stjohns.edu for
correspondence)


From owner-ageing@net.bio.net Sun Apr 17 23:00:00 1994
Path: biosci!agate!overload.lbl.gov!dog.ee.lbl.gov!ihnp4.ucsd.edu!swrinde!emory!europa.eng.gtefsd.com!howland.reston.ans.net!noc.near.net!das-news.harvard.edu!husc-news.harvard.edu!husc.harvard.edu!husc9.harvard.edu!gwmartin
Newsgroups: bionet.molbio.ageing
Subject: Re: fas gene
Message-ID: <2opkt4$hem@scunix2.harvard.edu>
From: gwmartin@husc9.harvard.edu (glover martin)
Date: 16 Apr 1994 21:21:40 GMT
References: <199404152120.OAA26594@net.bio.net>
Distribution: bionet
Organization: Harvard University, Cambridge, Massachusetts
NNTP-Posting-Host: husc9.harvard.edu
X-Newsreader: TIN [version 1.2 PL1]
Lines: 16

VERPHELD@VTVM1.CC.VT.EDU wrote:
: Autoimmune prone MRL/lpr mice have been reported to have deffective Fas genes
: which would presumably alter the negative selection process in the thymus.  I
: would like to know if anybody has any thoughtson why this deffective fas gene w
: ould alter T cell development and yet have no effect on other developmental
: processes mediatred through apoptosis.
: ************************************************************************
:   Daniela I. Verthelyi
:   Virgina Tech.
:   USA
:   VERPHERLD@VTVM1

Could there be many ways to start the "program" of apoptosis?  If this is 
the case, could fas be T-cell/T-cell precursor specific?

Trei

From owner-ageing@net.bio.net Mon Apr 18 23:00:00 1994
Path: biosci!agate!howland.reston.ans.net!noc.near.net!news.delphi.com!usenet
From: jarice@delphi.com
Newsgroups: bionet.molbio.ageing
Subject: Re: Aging rates/human vs. dog
Date: Tue, 19 Apr 94 01:20:34 -0500
Organization: Delphi (info@delphi.com email, 800-695-4005 voice)
Lines: 10
Message-ID: <puwP7wa.jarice@delphi.com>
References: <1994Apr14.235840.7253@mr.med.ge.com>
NNTP-Posting-Host: delphi.com
X-To: David Hinz W-641 548-3221 <hinz@wind>

David Hinz W-641 548-3221 <hinz@wind> writes:
 
>Why do dogs often have cataracts when they reach the age of, say, 12 years,
>but in humans it takes maybe 5 times as long?  Are the cells aging at a
>different rate, and if so, why?  If we knew why, could we do something 
>about affecting aging rates?
 
One answer may be the much higher levels of antioxidants present in
longer-lived animals, including man. Several recent studies also show
that antioxidant supplementation may delay or prevent cataract formation.

From owner-ageing@net.bio.net Tue Apr 19 23:00:00 1994
Path: biosci!daresbury!not-for-mail
From: "Leonid Gavrilov" <gavrilov@aeiveos.uucp.free.msk.su>
Newsgroups: bionet.molbio.ageing
Subject: Request for assistance
Date: 20 Apr 1994 21:16:10 +0100
Organization: A.N.Belozersky Institute, Moscow State University
Lines: 50
Sender: daemon@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <2p42ia$akk@mserv1.dl.ac.uk>
X-Russian: Cyrillic
Original-To: AGEING@dl.AC.UK


TO: <ageing@DARESBURY.AC.UK>

FROM:

Dr. Leonid A.Gavrilov, Ph.D. <aeiveos@glas.apc.org>
A.N.Belozersky Institute
Moscow State University
119899 Moscow, RUSSIA
FAX: 7 (095) 939-0338
     7 (095) 939-3181

April 20, 1994

   Dear Sirs,

   I am a Russian gerontologist trying to establish international 
scientific contacts. 

   Since my previous attempts to subscribe to this LISTSERV and 
to receive the mail address of other subscribers were so far 
unsuccessful, I would be most grateful for any advice and instruction 
how to solve this problem.

   Please send your response to my E-mail address:

             aeiveos@glas.apc.org

   Thank you in advance for your kindness.

   Sincerely yours,

   Dr.Leonid A.Gavrilov, Ph.D.
-- 

________________________________________________________________
-- Dr. Leonid A. Gavrilov, Ph.D.   Phone: 7 (095) 427 0047 
   Principal Research Scientist    FAX: 7 (095) 939 0338 or 
   A.N.Belozersky Institute             7 (095) 939 3181 
   Moscow State University         E-mail addresses: 
   Moscow 119899                   gavrilov@aeiveos.uucp.free.msk.su   
   Russia                             libro@genebee.msu.su
                                    aeiveos@glas.apc.org

   Please send your answer to my most reliable E-mail address:

                     aeiveos@glas.apc.org

   if you wish to be sure to reach me. Thank you !
___________________________________________________________________

From owner-ageing@net.bio.net Wed Apr 20 23:00:00 1994
Path: biosci!daresbury!not-for-mail
From: Mail Delivery System <postmaster@alf1.ngate.uni-regensburg.de>
Newsgroups: bionet.molbio.ageing
Subject: Delivery failure notification
Date: 21 Apr 1994 02:32:30 +0100
Lines: 68
Sender: daemon@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <2p4l3e$csn@mserv1.dl.ac.uk>
Original-To: <VERPHELD@VTVM1.CC.VT.EDU>

----------------------------Original message----------------------------


With reference to your message with the subject:
   "fas gene"

One or more addresses in your message have failed with the following
responses from the mail transport system:

   <jonas@alf1.ngate.uni-regensburg.de>
   File creation error delivering to 'jonas'.

Should you need assistance, please mail postmaster@alf1.ngate.uni-regensburg.de.

-------------------- Returned message follows ---------------------

Return-path: <VERPHELD@VTVM1.CC.VT.EDU>
Received: from ngate.rz.uni-regensburg.de by alf1.ngate.uni-regensburg.de
 (Mercury 1.11);
    Fri, 15 Apr 94 23:55:18 MET-1
Received: from VTVM1.CC.VT.EDU by ngate.rz.uni-regensburg.de; Fri, 15 Apr 94
 23:53 GMT
Received: from ib.rl.ac.uk by comsun.rz.uni-regensburg.de with SMTP id AA15420
  (5.65c/IDA-1.4.4 for <jonas@alf1.ngate.uni-regensburg.de>); Fri, 15 Apr 1994
 23:53:29 +0200
Received: from letterbox.rl.ac.uk by ib.rl.ac.uk (IBM VM SMTP V2R1) with TCP;
   Fri, 15 Apr 94 22:56:39 BST
Received: from dl.ac.uk by pserv1.dl.ac.uk with SMTP (PP-6.0)
          id <02854-0@pserv1.dl.ac.uk>; Fri, 15 Apr 1994 22:51:25 +0100
Received: by mserv1.dl.ac.uk id WAA04408 (8.6.6.Beta8/5.3[ref pg@dl.ac.uk]
          for dl.ac.uk from server-daemon@dl.ac.uk);
          Fri, 15 Apr 1994 22:49:38 +0100
Received: by mserv1.dl.ac.uk id WAA04394 (8.6.6.Beta8/5.3[ref pg@dl.ac.uk]
          for dl.ac.uk from server-daemon@dl.ac.uk);
          Fri, 15 Apr 1994 22:49:07 +0100
Received: by mserv1.dl.ac.uk id WAA04279 (8.6.6.Beta8/5.3[ref pg@dl.ac.uk]
          for dl.ac.uk from news@dl.ac.uk); Fri, 15 Apr 1994 22:48:26 +0100
Via: uk.ac.dl.pserv1; Fri, 15 Apr 1994 22:49:59 +0100
Resent-From: server-daemon <server-daemon@dl.ac.uk>
Date: 15 Apr 1994 14:20:27 -0700
Resent-Date: Fri, 15 Apr 94 22:49:32 UT
Message-Id: <94415224932.~INN-KREa00158.bionet-news@dl.ac.uk>
Resent-Message-Id: <199404152120.OAA26594@net.bio.net>
Precedence: list
From: VERPHELD@VTVM1.CC.VT.EDU
Reply-To: VERPHELD@VTVM1.CC.VT.EDU
Original-Sender: "bionet.molbio.ageing mail newsgroup" <server-daemon@dl.ac.uk>
To: "bionet.molbio.ageing mail newsgroup" <bionet-news@dl.ac.uk>
Subject: fas gene
Comments: List problems/queries to <biosci@daresbury.ac.uk>
Comments: To mail both the group and netnews send to (ageing@dl.ac.uk)
X-Article-Number: bionet.molbio.ageing Msg # 437
X-Listpath: bionet-news
X-Mailer: MXT V 12.16.1
Content-Length: 489
Content-Type: text
Sender: server-daemon@dl.ac.uk

Autoimmune prone MRL/lpr mice have been reported to have deffective Fas genes
which would presumably alter the negative selection process in the thymus.  I
would like to know if anybody has any thoughtson why this deffective fas gene w
ould alter T cell development and yet have no effect on other developmental
processes mediatred through apoptosis.
************************************************************************
  Daniela I. Verthelyi
  Virgina Tech.
  USA
  VERPHERLD@VTVM1

From owner-ageing@net.bio.net Wed Apr 20 23:00:00 1994
Path: biosci!daresbury!trane.uninett.no!sunic!pipex!howland.reston.ans.net!gatech!swrinde!ihnp4.ucsd.edu!munnari.oz.au!newsroom.utas.edu.au!sd_chin@postoffice.utas.edu.au
From: sd_chin@postoffice.utas.edu.au (Devika Chin)
Newsgroups: bionet.molbio.ageing
Subject: Autoimmunity in later life?
Date: 21 Apr 1994 01:22:42 GMT
Organization: University of Tasmania
Lines: 7
Distribution: world
Message-ID: <2p4kh2$1h1@franklin.cc.utas.edu.au>
NNTP-Posting-Host: clinicals100h46.med.utas.edu.au

Some investigators have hypothesied that the neuronal death in the aged could 
be due to autoimmunity that is expressed in later life.

Is there any substantial evidence that supports this hypothesis?

Does complement activation play a role in causing cell death?


From owner-ageing@net.bio.net Fri Apr 22 23:00:00 1994
Path: biosci!daresbury!not-for-mail
From: "Leonid Gavrilov" <gavrilov@aeiveos.uucp.free.msk.su>
Newsgroups: bionet.molbio.ageing
Subject: Looking for scientific contacts
Date: 23 Apr 1994 17:40:29 +0100
Organization: A.N.Belozersky Institute, Moscow State University
Lines: 322
Sender: daemon@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <2pbj1t$2f8@mserv1.dl.ac.uk>
X-Russian: Cyrillic
Original-To: AGEING@dl.AC.UK


April 23, 1994

Dear Sirs,

   Please allow me to introduce myself. I am a Russian scientist 
interested in ageing research and a new subscriber to this List. 

   I would like to establish scientific contacts and perhaps scientific 
collaboration with those who are interested in the problems of longevity 
and biology of life span. 

   My CV is printed below for more detailed introduction.

   Sincerely yours,

   Dr.Leonid A.Gavrilov, Ph.D.
   Member of the New York Academy of Sciences
*********************************************************************
                                                     March 26, 1994
                                        
               C U R R I C U L U M    V I T A E  
 
Dr. Leonid A. Gavrilov, Ph.D.          Phone: 7 (095) 427 0047 
Principal Research Scientist           FAX: 7 (095) 939 0338 or 
A.N.Belozersky Institute                    7 (095) 939 3181 
Moscow State University                E-mail addresses: 
Moscow 119899                          libro@genebee.msu.su 
Russia                             gavrilov@aeiveos.uucp.free.msk.su
                                        aeiveos@glas.apc.org 
 
Date of Birth: August 28, 1954 
Place of Birth: USSR (Russia), town of Sverdlovsk (now Ekaterinburg) 
Research interests: Mechanisms of ageing, age-related mortality,         
                    longevity. 
 
Education: 
   Ph.D. - Moscow State University (1980) in mortality kinetics 
           in human populations and animal models, with emphasis 
           on mathematical models of mortality. 
   M.Sc. - Moscow State University (1976) in mechanisms of aging 
           with emphasis on mathematical models of aging 
  
Professional Experience: 
 
1991-Present  Principal Research Scientist, A.N.Belozersky Institute, 
              Moscow State University. 
1987-1991   Senior Research Scientist, A.N.Belozersky Institute, 
            Moscow State University. 
1980-1987   Research Scientist, A.N.Belozersky Institute, 
            Moscow State University. 
 
Professional Activities and Other Positions:
   - Member of the New York Academy of Science. 
   - Chairman of the Subsection of the Biology of Life Span at 
        Moscow Society of Naturalists (1981-1992).
   - Expert (book reviewer) for journals AGE AND AGEING, AGEING 
        AND SOCIETY, J.GENERAL BIOLOGY and Publishers "MIR". 
   - Expert (peer reviewer) for journals MATHEMATICAL POPULATION 
        STUDIES, J.GENERAL BIOLOGY. 
   - Chairperson of the Biological Session at the II European 
        Congress of Gerontology (Madrid, 1991). Certificate signed 
        by F.Guillen Llera, General Secretary of the Congress. 
   - Expert (book editor) for Institute of Scientific Information 
        (VINITI, Moscow). 
   - Fellow of Moscow Society of Naturalists.
   - Senior Research Scientist at the Russian Academy of Sciences 
        Institute for System Analysis. 
   - Scientific Secretary of Demographic Section of Moscow House 
        of Scientists (1984-1991). 
   - Fellow of the Moscow House of Scientists. 

Awards: 

   - International Science Foundation (ISF) 1993 Grant Award ($500).
   - International Science Foundation (ISF) 1994 Emergency Grant for 
        Russian Scientists of the Top Category ($3,000)
   - The Certificate from the International Association of Gerontology 
        (1993) signed by the President and the Secretary General of the 
        International Association of Gerontology. 
   - A.N.Belozersky Institute 1991 Award for the best scientific 
        research in the Institute in 1990-1991. 
   - Moscow Society of Naturalists 1989 Award for the best scientific 
        research in natural science in 1986-1988. 
   - Grant Award with invitation to European Population Conference 
        (Paris, October 1991). 
   - Financial Award with invitation of giving a lectures to Trinity 
        College, Cambridge University (December, 1991). 
   - Financial Award with invitation to the Annual Meeting of British 
        Biochemical Society (Southampton, April, 1992). 
  
Publications: 
65 publications, including 5 books.  Selected publications in the most 
prestigeous scientific peer reviewed journals are:
  
    - "Sex and Longevity", Nature, 1994, vol.367, February 10, p.520.
    - "Fruit Fly Aging and Mortality", Science, 1993, vol.260, No.5114,
          p.1565. 
    - "When Your Time's Up", British Medical Journal, 1993, vol.306, 
          No.6880, p.796.
    - "Human Life Span Stopped Increasing: Why?", Gerontology, 1983,
          vol.29, pp.176-180. 
    - "Life Span is Determined by Resting Metabolic Rate of Parents 
          Only!", Age, 1989, vol.12, p.113. 
    - "Human Species-Specific Life-Span: Its Estimation and  
          Interpretation", Age, 1985, vol.8, p.94. 
    - "A New Trend in Human Mortality Decline: Derectangularization 
          of the Survival Curve", Age, 1985, vol.8, p.93. 
    - "Biology of Aging (Book Review)", Age and Ageing, 1993, vol.22,
          pp.233-234. 
   - "Evolutionary Biology of Aging (Book Review)", Ageing and 
          Society, 1992, vol.12, No.4, pp.539-541. 
    - "How Many Cell Divisions in 'Old' Cells?", International Journal 
          of Geriatric Psychiatry, 1993, vol.8, No.6, p.528. 
    - "Common Sense and the Limits to Life", International Journal of 
          Geriatric Psychiatry, 1993, vol.8, No.8, p.695. 
    - "Historically Stable Indices of Mortality and their Use for 
          Medical Geography", Geographia Medica, 1984, vol.14, 
          pp.305-306. 
    - "Epidemiologic Approach to the Biology of Human Life Span", 
          Geographia Medica, 1985, vol.15, pp.40-64. 

    The key publication where the main results of the previous studies 
are summarised is: 

        THE BIOLOGY OF LIFE SPAN: A QUANTITATIVE APPROACH.        

By Leonid A.Gavrilov and Natalia S.Gavrilova. Harwood  Academic 
Publishers: 1991. Pp. 385, $ 120, ISBN 3-7186-4983-7.

   Positive reviews of this book were published by  the  following 
journals: 

 1. AGE AND AGEING, 1992, vol.21, No.5, pp.386-387. 
 2. AGEING AND SOCIETY, 1991, vol.11, No.4, pp.509-510.
 3. ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1992, vol.15, No.2, pp.192-194. 
 4. ARGOMENTI DI GERONTOLOGIA, 1993, vol.5, No.2, p.91.
 5. BIOESSAYS, 1993, vol.15, No.5, pp.359-362. 
 6. BOLLETTINO DELLA SOCIETA ITALIANA DI GERONTOLOGIA E GERIATRIA, 1992, 
    No.7, p.1.
 7. BRITISH MEDICAL JOURNAL, 1992, vol.305, No.6850, p.431. 
 8. EDUCATIONAL GERONTOLOGY, 1993, vol.19, No.1, pp.92-93. 
 9. EXPERIMENTAL GERONTOLOGY, 1992, vol.27, pp.251-253. 
10. FREE RADICAL BIOLOGY & MEDICINE, 1992, vol.12, pp.331-332. 
11. GERONTOLOGIST, 1991, vol.31, No.5, p.707.
12. HUMAN BIOLOGY, 1992, vol.64, No.4, pp.630-632.  
13. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1992, vol.7, No.8, p.614. 
14. JOURNAL OF CROSS-CULTURAL GERONTOLOGY, 1993, vol.8, No.3, pp.281-290.
15. JOURNAL OF EPIDEMIOLOGY & COMMUNITY HEALTH, 1992, vol.46, No.6, p.630. 
16. JOURNAL OF THE INSTITUTE OF ACTUARIES, 1992, vol.119, Part II, 
    pp.379-381. 
17. JOURNAL OF ORTHOMOLECULAR MEDICINE, 1993, vol.8, No.1, pp.59-60. 
18. NATURE, 1991, vol.352, 29 August, pp.767-768. 
19. POPULATION AND DEVELOPMENT REVIEW, 1992, vol.18, No.3, pp.555-558.
20. POPULATION STUDIES, 1992, vol.46, No.2, pp.366-367. 
21. QUARTERLY REVIEW OF BIOLOGY, 1993, vol.68, p.92. 
22. STATISZTIKAI SZEMLE (STATISTICAL REVIEW, In Hungarian), 
    1992,vol.70,No.6,pp.546-547.


Response of the Leading Scientists to the Scientific Research  and 
the Book by L.A.Gavrilov: 
 
"HIGHLY RECOMMENDED FOR STIMULATING FRESH APPROACHES ... " - 
Professor Roy L.Walford, M.D., UCLA School of Medicine, USA. 
   THE GERONTOLOGIST, 1991, vol.31, No.5, p.707. 
 
 
"CLEARLY,  THIS   IS   A   VERY   INTERESTING,   PROVOCATIVE   AND 
THOUGHT-PROVOKING BOOK" - Dr. Ward  Dean,  M.D.,  The  Center  for 
Bio-Gerontology,  Pencasola,  Florida,  USA. 
   EXPERIMENTAL GERONTOLOGY, 1992, vol.27, No.2, pp.251-253. 
 
 
"THIS IS  AN  INTERESTING  BOOK,  FULL  OF  TABLES  AND  DATA  AND 
POLEMICAL IN ITS APPROACH." - Professor William A.Pryor,  Director 
of Biodynamic Institute, Louisiana State University, Baton  Rouge, 
LA,USA. 
   FREE RADICAL BIOLOGY & MEDICINE, 1992, vol.12, pp.331-332. 
 
"IT BRINGS TO BEAR A FRESH  APPROACH  WHOSE  IDEAS  ARE  LOGICALLY 
PRESENTED AND DEVELOPED". - Dr. Brian Merry, Ph.D., Institute  of 
Human  Aging, University of Liverpool, United Kingdom. 
   AGEING AND SOCIETY, 1991, vol.11, No.4, pp.509-510. 
 
 
"GOOD NEW BOOK ON AGEING". - Dr. Thomas B.L.Kirkwood, Ph.D. 
Head of the Laboratory of Mathematical Biology, National
Institute for Medical Research, London, United Kingdom. 
   NATURE, 1991, vol.352, 29 August, pp.767-768. 
 
  
"... SHOULD BE READ BY ANYONE SERIOUSLY INTERESTED IN AGEING.  ... 
YOU WILL FIND THIS A SURPRISINGLY GOOD  'READ',  AND  A  MUST  FOR 
EVERY  LIBRARY".  -  Dr.   D.Sebastian   Fairweather,   Physician, 
   Department of Geriatric Medicine, Oxford, United Kingdom. 
   AGE AND AGEING, 1992, vol.21, No.5, pp.386-387. 
 
 
"THE BOOK FEATURES QUITE A BIT OF DEMOGRAPHIC THEORY AND ANALYSIS. 
.... IT IS REFRESHING"  -  Professor Michael R.Rose, University  of 
   California, Irvine, USA. 
   ANNALS OF HUMAN BIOLOGY, 1992, vol.19, No.3, pp.320-321. 
  
 
"THE GAVRILOVS HAVE MADE A VALUABLE CONTRIBUTION TO THE  STUDY  OF 
LIFE SPAN, AND ANY FUTURE WORK ON THE SUBJECT WILL  HAVE  TO  TAKE 
ACCOUNT OF THE RICH CONTENTS OF THIS BOOK". - Dr. Vaino Kannisto, 
Former United Nations Adviser on Demography 
   POPULATION STUDIES, 1992, vol.46, No.2, pp. 366-367. 
   
"EIN AKTUELLES BUCH, DAS SICHERLICH DIE INTERNATIONALE 
DISKUSSION DES PROBLEMS BEFORDERN KANN." 
 - Prof. Dr. Ingeborg Falck, Berlin, Germany. 
   ZEITSCHRIFT FUR GERONTOLOGIE, 1991, Band 25, Heft 1, S.56. 
 
 
"THE BOOK IS WELL WRITTEN, EASY TO READ, AND SHOULD BE OF INTEREST 
TO A WIDE SPECTRUM OF READERS  INCLUDING  PHYSICIANS,  BIOLOGISTS, 
BIOCHEMISTS, GERONTOLOGISTS..." 
 - Prof. Robert W.Gracy, University of North Texas, USA. 
   EDUCATIONAL GERONTOLOGY, 1993, vol.19, No.1, pp.92-93. 
 
"...  THIS  BOOK  IS  A  HIGHLY  VALUABLE  CONTRIBUTION   TO   THE 
DISCIPLINE. ...THIS BOOK SHOULD MAKE  SCIENTISTS  TAKE  NOTICE  OF 
RESEARCH ON AGING AND LONGEVITY ... IN THE FORMER SOVIET UNION" - 
    Dr.  S.Jay Olshansky, Ph.D., University of Chicago, USA  
POPULATION AND DEVELOPMENT REVIEW, 1992, vol.18, No.3, pp.555-558.
 
"... MANY WILL FIND AN EXCURSION INTO IT STIMULATING". 
 - Dr. Emily Grundy, Lecturer in Gerontology, Age Concern 
   Institute of Gerontology, King's College, London, UK. 
   BRITISH MEDICAL JOURNAL, 1992, vol.305, No.6850, p.431. 
 
"GAVRILOV MAKES THE BEST ATTEMPT I KNOW OF TO DISTINGUISH HOW LONG 
PEOPLE COULD LIVE FROM HOW LONG THEY ACTUALLY LIVE -  ONE  OF  THE 
MORE DIFFICULT TASKS FOR BOTH BIOLOGY AND STATISTICS... GAVRILOV'S 
SCHOLARSHIP  IS   IMPRESSIVE".   -   Professor   Nathan   Keyfitz, 
   International   Institute   for   Applied   Systems   Analysis, 
   Laxenburg, Austria.
   MATHEMATICAL POPULATION STUDIES, 1991, vol.3, No.2, p.161. 
                                                            
"LEONID  GAVRILOV   IS   A   TOP-FLIGHT   STATISTICAL   POPULATION 
BIOLOGIST... THE AREA IS IMPORTANT WELL  BEYOND  THE  CONFINES  OF 
BIOLOGICAL  GERONTOLOGY  AND  EXTENDS  INTO  POLITICS  AND  SOCIAL 
PLANNING. GAVRILOV IS VERY GOOD ON JUST THIS SORT OF THING. HE HAS 
A FRESH APPROACH, NEW IDEAS, A GREAT  DEAL  OF  DATA  NOT  READILY 
AVAILABLE ELSEWHERE." - Roy. L. Walford, Professor  of  Pathology, 
   UCLA School of Medicine, USA. 
   MATHEMATICAL POPULATION STUDIES, 1991, vol.3, No.2, p.161. 
 
  
"THIS  BOOK  IS  DIRECTED   TOWARD   RESEARCHERS   INTERESTED   IN 
STATISTICAL PATTERNS AND MATHEMATICAL MODELS OF HUMAN  LIFE  SPAN. 
FOR STUDENTS WITHIN THIS  DEFINED  AREA  OF  RESEARCH,  THIS  TEXT 
OFFERS A GOOD HISTORICAL PERSPECTIVE,  INSIGHT  INTO  THE  RUSSIAN 
LITERATURE, AND INSIGHT INTO THE  QUANTITATIVE  ANALYSIS  OF  LIFE 
SPAN"   -   Dr.  Deborah  A.Roach,  Department  of  Zoology, 
    Duke University, Durham, USA. 
    ECOLOGY, 1992, vol.73, No.1, pp.379-381. 
 
 
"THIS BOOK IS IN ESSENCE A BIOSTATISTICAL ANALYSIS OF THE PROBLEMS 
OF  LIFESPAN,  HUMAN  AND  ANIMAL.  ...  THE  LITERATURE  IN  MANY 
LANGUAGES HAD CLEARLY BEEN WELL COVERED, AND MUCH HAS BEEN MADE OF 
NATIONAL AND OTHER MORTALITY STATISTICS IN  THIS  CENTURY.  ... 
A USEFUL SOURCE BOOK." - Dr. F.I.Caird, D.M., F.R.C.P.,  Professor 
   of Geriatric Medicine, Southern General Hospital, Glasgow, UK.
   J. OF CLINICAL AND EXPERIMENTAL GERONTOLOGY, 1992, vol.14, 
   No. 3 & 4, p.309. 
 
"... THE READER WILL BENEFIT ENORMOUSLY  FROM  THE  BROADENING  OF 
PERSPECTIVE AS A RESULT OF EXPOSURE TO THE GAVRILOVS' THEORIES  ON 
THE BIOLOGY OF LIFE SPAN"    -   Dr. M. Michael  Akiyama, 
   University of Michigan, Dearborn, USA. 
   HUMAN BIOLOGY, 1992, vol.64, No.4, pp.630-632. 
 
 
"THIS IS A PROVOCATIVE AND REFRESHING BOOK" - Dr.Alan R.Hipkiss, 
   Age Concern Institute of Gerontology, King's College London, UK. 
 INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1992, vol.7,No.8,p.614. 
 
 
"THIS BOOK SHOULD  BE  READ  BY  ALL  MEMBERS  OF  THE  PROFESSION 
INTERESTED IN MORTALITY - WHICH  SHOULD  BE  ALL  MEMBERS  OF  THE 
PROFESSION" -  Dr. H.A.R.Barnett, Institute of Actuaries, UK. 
 J.OF THE INSTITUTE OF ACTUARIES, 1992, vol.119, Part II, pp.379-381.
 
"TO SUM UP, THE BOOK IS SUBSTANTIAL, INTERESTING AND BRINGS  FRESH 
AIR. WE CAN CONFIDENTLY COMMEND ITS STUDY TO ALL SCIENTISTS ... " 
   - Dr. Janos Izsak, Department of Zoology, Berzsenyi Teachers' 
   College, Szombathely, Hungary. 
ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1992, vol.15, No.2,pp.192-194.
 
"A GENERAL THEORY OF LIFESPAN IS THUS CREATED." - 
 - Dr. Norman Vetter, University Hospital of Wales, Cardiff, UK. 
J.OF EPIDEMIOLOGY & COMMUNITY HEALTH, 1992, vol.46, No.6, p.630. 
 
"I FOUND IT TO BE HIGHLY REWARDING READING." -  
   Dr. Edward J.Masoro, University of Texas Health Science Center.
   QUARTERLY REVIEW OF BIOLOGY, 1993, vol.68, p.92. 
 
 
"THIS ... IS AN EXCELLENT BOOK. ... NOBODY INTERESTED IN AGING SHOULD   
FAIL TO READ". - 
   Dr. C.S.Downes, Department of Zoology, University of Cambridge, UK. 
   BIOESSAYS, 1993, vol.15, No.5, pp.359-362. 


"...PROVOCATIVE AND ENTERTAINING READING AND CAN BE RECOMMENDED TO 
ANYONE WITH AN INTEREST IN BIOLOGICAL AGING." - 
   Dr. Douglas E.Crews, Department of Anthropology, Ohio State 
   University, USA
   JOURNAL OF CROSS-CULTURAL GERONTOLOGY, 1993, vol.8, No.3, pp.281-290.


"IT DESERVES TO BE READ WIDELY. SCIENTISTS AND PHYSICIANS WHO ARE 
INTERESTED IN THE AGING OF POPULATIONS OR OF INDIVIDUALS WILL BE MUCH 
MORE EFFECTIVE IN THEIR WORK IF THEY BECOME FAMILIAR WITH THE SUBJECT 
MATTER OF THIS BOOK." - 
    JOURNAL OF ORTHOMOLECULAR MEDICINE, 1993, vol.8, No.1, pp.59-60. 
*********************************THE END************************************

From owner-ageing@net.bio.net Fri Apr 22 23:00:00 1994
Path: biosci!agate!howland.reston.ans.net!gatech!newsxfer.itd.umich.edu!jobone!lynx.unm.edu!news.cs.indiana.edu!babbage.ece.uc.edu!mary.iia.org!rtp.vnet.net!news.sprintlink.net!news.world.net!news.teleport.com!news.teleport.com!not-for-mail
From: jor@teleport.com (Jo Robinson)
Newsgroups: bionet.molbio.ageing
Subject: melatonin
Date: 23 Apr 1994 15:13:08 -0700
Organization: Teleport - Portland's Public Access (503) 220-1016
Lines: 13
Message-ID: <2pc6hk$hrp@linda.teleport.com>
NNTP-Posting-Host: linda.teleport.com
X-Newsreader: TIN [version 1.2 PL2]

I am a freelance journalist researching a book for the 
educated public on melatonin, the pineal hormone.  I am
interested in its anti-aging, oncostatic, immunoenhancing,
antioxidant properties.  I would very much like to
talk to researchers involved -- or interested -- in this
fast-growing field.  I'm particularly interested in
finding out if anyone is doing primate or human longevity
trials.  But any input is appreciated.
-- 
+-----------------------------------+-----------------------------------------+
|       Jo Robinson		    |            jor@teleport.com             |
|      (503)284-4676                |     2826 NE 18th Portland, OR 97212     | 
+-----------------------------------+------------------------------------y-----+

From owner-ageing@net.bio.net Sat Apr 23 23:00:00 1994
Path: biosci!agate!howland.reston.ans.net!pipex!uknet!daresbury!not-for-mail
From: "Leonid Gavrilov" <gavrilov@aeiveos.uucp.free.msk.su>
Newsgroups: bionet.molbio.ageing
Subject: Urgent grant for ageing research
Date: 24 Apr 1994 09:14:40 +0100
Organization: A.N.Belozersky Institute, Moscow State University
Lines: 31
Sender: daemon@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <2pd9pg$1j2@mserv1.dl.ac.uk>
X-Russian: Cyrillic
Original-To: AGEING@dl.AC.UK


April 24, 1994

Dear Sirs, 

   The purpose of this message is to invite you to join a research 
team for receiving EC grant called COPERNICUS. 

   In order to receive this grant a team of 5 researchers from 
5 different countries should be created: 2 researchers from EC countries, 
2 researchers from Eastern European countries and 1 researcher from 
the countries of the former Soviet Union (myself). Additional researchers 
from other eligible countries are very much wellcome. Of special 
importance is participant from Belgium since the COPERNICUS  Headquarters 
is located there and it is extremely important to have an opportunity 
for personal contact with COPERNICUS administration. 

   The suggested topics of the grants are: 
1. Parental age an offspring longevity. 
2. Biomedical basis for sex differences in life span. 
3. Any other topics could be negotiated. 

   The deadline for application is May 2, 1994. So, we are to be very rapid !

   Sincerely yours,

   Dr.Leonid A.Gavrilov, Ph.D.
   Member of the New York Academy of Sciences

P.S.: My CV is available upon the request or could be extracted from 
archives of this LIST (message 447 of April 23). 

From owner-ageing@net.bio.net Sat Apr 23 23:00:00 1994
Path: biosci!DRUID.HSC.COLORADO.EDU!mandy
From: mandy@DRUID.HSC.COLORADO.EDU (Mandy Caird PhD)
Newsgroups: bionet.molbio.ageing
Subject: CANCER, AGING AND TH
Date: 24 Apr 1994 12:27:40 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 63
Sender: daemon@net.bio.net
Distribution: bionet
Message-ID: <Pine.3.89.9404241334.A1581-0100000@druid>
Reply-To: Mandy Caird PhD <mandy@druid.hsc.colorado.edu>
NNTP-Posting-Host: net.bio.net

Dear all on the ageing list!

        I recently read an article in U.S. News and World Report on
immortal cancer cells.  The article went on to discuss how cancer cells are
immortal because the produce the Telomerase enzyme which rejuvenates the
Telomeres at the ends of the DNA strands in the cells which prevents the
aging or senecesing of the cells.  The article further discussed how this
may allow researchers to target cancer cells since most human cells no
longer produce Telomerase and are mortal.  It may eventually may lead to a
more specific way of fighting cancer, as opposed to the blunt approach of chemotherapy.

        A side issue dealt with in the article was that almost all cells in
an adult human no longer produce Telomerase and are mortal, with the
exception of certain cells in bone marrow and the male testicles.   Mortal
cells can only reproduce 50 to 100 times before degrading quite rapidly,
whereas the cancer cells can reproduce acurately forever.

        This raised several questions in my mind.  I realize that there is
probably no current yes or no answers to these questions, but your insight
and informed commentary on my questions would be greatly appreciated.  My
questions are as follows:

        1. Is there a direct correlation between human aging (growing old)
           and the shorten of Telomeres thru cellular reproduction in
           normal human mortal cells?


        2. If the enzyme telomerase were introduced into a normal mortal
	human cells could it extend the longevity and quality of a human
           life by repairing chromosomal instability and chromosome damage?
           Perhaps, eliminate death from old age?


        2. a) Would this enzyme treatment only be temporary or permanent,
              and if it is temporary would regular and periodic
              introduction of this enzyme into the cell perform the same
              function as if the Telomerase enzyme were being constantly
              produced within the cell itself?

        3. Would the introduction of the enzyme Telomerase into a mortal
           human cell stabilize the Telomeres at the ends of the DNA
           at their current length or at a shorter or longer length?

        4. Is it feasable to reactivate the dormant chromosome responsible
           for the production of telomerase.

        5. In addition to the potential of Telomerase being able   to
	immortalize human mortal cells allowing them to replicate
           their DNA sequences accurately forever, would there be any
           potential side effects that would diminish the possible positive
           benefits from having this enzyme present in human cells?


                                   Thanks!!!

                                   Sincerely,



                                   Carl W. Weaver




From owner-ageing@net.bio.net Sat Apr 23 23:00:00 1994
Path: biosci!DRUID.HSC.COLORADO.EDU!mandy
From: mandy@DRUID.HSC.COLORADO.EDU (Mandy Caird PhD)
Newsgroups: bionet.molbio.ageing
Subject: Re: CANCER, AGING AND TH
Date: 24 Apr 1994 14:16:15 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 3
Sender: daemon@net.bio.net
Distribution: bionet
Message-ID: <Pine.3.89.9404241530.A1626-0100000@druid>
NNTP-Posting-Host: net.bio.net

Please reply to
 MR CARL W WEAVER <XGBU08A@prodigy.com>


From owner-ageing@net.bio.net Sun Apr 24 23:00:00 1994
Path: biosci!agate!howland.reston.ans.net!pipex!doc.ic.ac.uk!susx.ac.uk!bafa1
From: bafa1@central.susx.ac.uk (Sydney Shall)
Newsgroups: bionet.molbio.ageing
Subject: Telomerase
Date: 25 Apr 1994 09:09:28 GMT
Organization: University of Sussex
Lines: 26
Message-ID: <2pg1c8$kbu@infa.central.susx.ac.uk>
NNTP-Posting-Host: solx1.central.susx.ac.uk
X-Newsreader: TIN [version 1.2 PL2]

	The enzyme telomerase has been shown to be present in immortal
cell lines.  However, it has never been purified and therefore it has
never been cloned.

	The average length of telomeres in dividing normal,
untransformed cells has been shown to shorten as the cell culture ages. 
That is, there is a correlation between the length of the average
telomere size and the age of the culture.

	The predictions of what the re-introduction of a telomerase
enzyme might do in ageing cells requires the cloning of the gene for
this enzyme.  This is proving a very difficult task.

	In presence it should be possible to reactivate the expression
of this gene in normal cells, and to repress its expression in cancer
cells, but this also awaits the cloning of the gene.

	This area is therefore both very active and very excitibg, and
there is lots of room for more people in this field.


-- 
**************************************************************************

**************************************************************************


From owner-ageing@net.bio.net Sun Apr 24 23:00:00 1994
Path: biosci!agate!dog.ee.lbl.gov!ihnp4.ucsd.edu!swrinde!cs.utexas.edu!howland.reston.ans.net!pipex!uknet!daresbury!not-for-mail
From: "Leonid Gavrilov" <gavrilov@aeiveos.uucp.free.msk.su>
Newsgroups: bionet.molbio.ageing
Subject: Hayflick limit wrong ?
Date: 25 Apr 1994 17:32:33 +0100
Organization: A.N.Belozersky Institute, Moscow State University
Lines: 50
Sender: daemon@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <2pgrb1$p2o@mserv1.dl.ac.uk>
X-Russian: Cyrillic
Original-To: AGEING@dl.AC.UK



Dear AGEING LIST subscribers,

   I would like to know the current situation for the discovery of the 
authors mentioned below, that simple change of composition of the cell 
culture medium could eliminate cellular senescence: 

    Loo, D.T., Fuquay, J.I., Rawson, C.L. and Barnes, D.W. (1987). 
Extended culture of mouse embryo cells without senescence: inhibition by 
serum. Science 236, 200-202. 

   These authors demonstrated that normal diploid mouse embryo cells, which 
under standard conditions manifest a growth crisis after 7-10 population 
doublings, may be successfully cultivated without any sign of an 
approaching growth crisis for at least 200 population doublings. All that is 
necessary is to change the composition of the culture medium (excluding 
blood serum and adding a number of ingredients, including the epidermal 
growth factor). In this case the cells, which are apparently capable of 
unlimited multiplication, remain diploid and nontumorigenic.

   If that is true, then the claim of Dr.Hayflick that all diploid cells 
have intrinsic limit to cell division, is definitely wrong. 

   Does anybody know whether the results of these authors were reproduced 
or disproved ?  

   Does anybody knows the present addresses (E-mail in particular) of these 
authors ? 

   Thanks,

   Dr.Leonid A.Gavrilov, Ph.D.
-- 

________________________________________________________________
-- Dr. Leonid A. Gavrilov, Ph.D.   Phone: 7 (095) 427 0047 
   Principal Research Scientist    FAX: 7 (095) 939 0338 or 
   A.N.Belozersky Institute             7 (095) 939 3181 
   Moscow State University         E-mail addresses: 
   Moscow 119899                   gavrilov@aeiveos.uucp.free.msk.su   
   Russia                             libro@genebee.msu.su
                                    aeiveos@glas.apc.org

   Please send your answer to my most reliable E-mail address:

                     aeiveos@glas.apc.org

   if you wish to be sure to reach me. Thank you !
___________________________________________________________________

From owner-ageing@net.bio.net Sun Apr 24 23:00:00 1994
Path: biosci!aeiveos.uucp.free.msk.su!gavrilov
From: gavrilov@aeiveos.uucp.free.msk.su ("Leonid Gavrilov")
Newsgroups: bionet.molbio.ageing
Subject: Grant for Longevity Research
Date: 25 Apr 1994 10:38:19 -0700
Organization: A.N.Belozersky Institute, Moscow State University
Lines: 335
Sender: daemon@net.bio.net
Distribution: bionet
Message-ID: <2dba3297.aeiveos@aeiveos.uucp.free.msk.su>
Reply-To: "Leonid Gavrilov" <gavrilov@aeiveos.uucp.free.msk.su>
NNTP-Posting-Host: net.bio.net


April 24, 1994

Dear Sirs, 

   The purpose of this message is to invite you to join a research 
team for receiving EC grant called COPERNICUS. 

   In order to receive this grant a team of 5 researchers from 
5 different countries should be created: 2 researchers from EC countries, 
2 researchers from Eastern European countries and 1 researcher from 
the countries of the former Soviet Union (myself). Additional researchers 
from other eligible countries are very much wellcome. Of special 
importance is participant from Belgium since the COPERNICUS  Headquarters 
is located there and it is extremely important to have an opportunity 
for personal contact with COPERNICUS administration. 

   The suggested topics of the grants are: 
1. Parental age an offspring longevity. 
2. Biomedical basis for sex differences in life span. 
3. Any other topics could be negotiated. 

   The deadline for application is May 2, 1994. So, we are to be very rapid !

   Sincerely yours,

   Dr.Leonid A.Gavrilov, Ph.D.
   Member of the New York Academy of Sciences

P.S.: My CV is printed below for introduction.
**************************************************************************
                                                     March 26, 1994
                                        
               C U R R I C U L U M    V I T A E  
 
Dr. Leonid A. Gavrilov, Ph.D.          Phone: 7 (095) 427 0047 
Principal Research Scientist           FAX: 7 (095) 939 0338 or 
A.N.Belozersky Institute                    7 (095) 939 3181 
Moscow State University                E-mail addresses: 
Moscow 119899                          libro@genebee.msu.su 
Russia                             gavrilov@aeiveos.uucp.free.msk.su
                                        aeiveos@glas.apc.org 
 
Date of Birth: August 28, 1954 
Place of Birth: USSR (Russia), town of Sverdlovsk (now Ekaterinburg) 
Research interests: Mechanisms of ageing, age-related mortality,         
                    longevity. 
 
Education: 
   Ph.D. - Moscow State University (1980) in mortality kinetics 
           in human populations and animal models, with emphasis 
           on mathematical models of mortality. 
   M.Sc. - Moscow State University (1976) in mechanisms of aging 
           with emphasis on mathematical models of aging 
  
Professional Experience: 
 
1991-Present  Principal Research Scientist, A.N.Belozersky Institute, 
              Moscow State University. 
1987-1991   Senior Research Scientist, A.N.Belozersky Institute, 
            Moscow State University. 
1980-1987   Research Scientist, A.N.Belozersky Institute, 
            Moscow State University. 
 
Professional Activities and Other Positions:
   - Member of the New York Academy of Science. 
   - Chairman of the Subsection of the Biology of Life Span at 
        Moscow Society of Naturalists (1981-1992).
   - Expert (book reviewer) for journals AGE AND AGEING, AGEING 
        AND SOCIETY, J.GENERAL BIOLOGY and Publishers "MIR". 
   - Expert (peer reviewer) for journals MATHEMATICAL POPULATION 
        STUDIES, J.GENERAL BIOLOGY. 
   - Chairperson of the Biological Session at the II European 
        Congress of Gerontology (Madrid, 1991). Certificate signed 
        by F.Guillen Llera, General Secretary of the Congress. 
   - Expert (book editor) for Institute of Scientific Information 
        (VINITI, Moscow). 
   - Fellow of Moscow Society of Naturalists.
   - Senior Research Scientist at the Russian Academy of Sciences 
        Institute for System Analysis. 
   - Scientific Secretary of Demographic Section of Moscow House 
        of Scientists (1984-1991). 
   - Fellow of the Moscow House of Scientists. 

Awards: 

   - International Science Foundation (ISF) 1993 Grant Award ($500).
   - International Science Foundation (ISF) 1994 Emergency Grant for 
        Russian Scientists of the Top Category ($3,000)
   - The Certificate from the International Association of Gerontology 
        (1993) signed by the President and the Secretary General of the 
        International Association of Gerontology. 
   - A.N.Belozersky Institute 1991 Award for the best scientific 
        research in the Institute in 1990-1991. 
   - Moscow Society of Naturalists 1989 Award for the best scientific 
        research in natural science in 1986-1988. 
   - Grant Award with invitation to European Population Conference 
        (Paris, October 1991). 
   - Financial Award with invitation of giving a lectures to Trinity 
        College, Cambridge University (December, 1991). 
   - Financial Award with invitation to the Annual Meeting of British 
        Biochemical Society (Southampton, April, 1992). 
  
Publications: 
65 publications, including 5 books.  Selected publications in the most 
prestigeous scientific peer reviewed journals are:
  
    - "Sex and Longevity", Nature, 1994, vol.367, February 10, p.520.
    - "Fruit Fly Aging and Mortality", Science, 1993, vol.260, No.5114,
          p.1565. 
    - "When Your Time's Up", British Medical Journal, 1993, vol.306, 
          No.6880, p.796.
    - "Human Life Span Stopped Increasing: Why?", Gerontology, 1983,
          vol.29, pp.176-180. 
    - "Life Span is Determined by Resting Metabolic Rate of Parents 
          Only!", Age, 1989, vol.12, p.113. 
    - "Human Species-Specific Life-Span: Its Estimation and  
          Interpretation", Age, 1985, vol.8, p.94. 
    - "A New Trend in Human Mortality Decline: Derectangularization 
          of the Survival Curve", Age, 1985, vol.8, p.93. 
    - "Biology of Aging (Book Review)", Age and Ageing, 1993, vol.22,
          pp.233-234. 
   - "Evolutionary Biology of Aging (Book Review)", Ageing and 
          Society, 1992, vol.12, No.4, pp.539-541. 
    - "How Many Cell Divisions in 'Old' Cells?", International Journal 
          of Geriatric Psychiatry, 1993, vol.8, No.6, p.528. 
    - "Common Sense and the Limits to Life", International Journal of 
          Geriatric Psychiatry, 1993, vol.8, No.8, p.695. 
    - "Historically Stable Indices of Mortality and their Use for 
          Medical Geography", Geographia Medica, 1984, vol.14, 
          pp.305-306. 
    - "Epidemiologic Approach to the Biology of Human Life Span", 
          Geographia Medica, 1985, vol.15, pp.40-64. 

    The key publication where the main results of the previous studies 
are summarised is: 

        THE BIOLOGY OF LIFE SPAN: A QUANTITATIVE APPROACH.        

By Leonid A.Gavrilov and Natalia S.Gavrilova. Harwood  Academic 
Publishers: 1991. Pp. 385, $ 120, ISBN 3-7186-4983-7.

   Positive reviews of this book were published by  the  following 
journals: 

 1. AGE AND AGEING, 1992, vol.21, No.5, pp.386-387. 
 2. AGEING AND SOCIETY, 1991, vol.11, No.4, pp.509-510.
 3. ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1992, vol.15, No.2, pp.192-194. 
 4. ARGOMENTI DI GERONTOLOGIA, 1993, vol.5, No.2, p.91.
 5. BIOESSAYS, 1993, vol.15, No.5, pp.359-362. 
 6. BOLLETTINO DELLA SOCIETA ITALIANA DI GERONTOLOGIA E GERIATRIA, 1992, 
    No.7, p.1.
 7. BRITISH MEDICAL JOURNAL, 1992, vol.305, No.6850, p.431. 
 8. EDUCATIONAL GERONTOLOGY, 1993, vol.19, No.1, pp.92-93. 
 9. EXPERIMENTAL GERONTOLOGY, 1992, vol.27, pp.251-253. 
10. FREE RADICAL BIOLOGY & MEDICINE, 1992, vol.12, pp.331-332. 
11. GERONTOLOGIST, 1991, vol.31, No.5, p.707.
12. HUMAN BIOLOGY, 1992, vol.64, No.4, pp.630-632.  
13. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1992, vol.7, No.8, p.614. 
14. JOURNAL OF CROSS-CULTURAL GERONTOLOGY, 1993, vol.8, No.3, pp.281-290.
15. JOURNAL OF EPIDEMIOLOGY & COMMUNITY HEALTH, 1992, vol.46, No.6, p.630. 
16. JOURNAL OF THE INSTITUTE OF ACTUARIES, 1992, vol.119, Part II, 
    pp.379-381. 
17. JOURNAL OF ORTHOMOLECULAR MEDICINE, 1993, vol.8, No.1, pp.59-60. 
18. NATURE, 1991, vol.352, 29 August, pp.767-768. 
19. POPULATION AND DEVELOPMENT REVIEW, 1992, vol.18, No.3, pp.555-558.
20. POPULATION STUDIES, 1992, vol.46, No.2, pp.366-367. 
21. QUARTERLY REVIEW OF BIOLOGY, 1993, vol.68, p.92. 
22. STATISZTIKAI SZEMLE (STATISTICAL REVIEW, In Hungarian), 
    1992,vol.70,No.6,pp.546-547.


Response of the Leading Scientists to the Scientific Research  and 
the Book by L.A.Gavrilov: 
 
"HIGHLY RECOMMENDED FOR STIMULATING FRESH APPROACHES ... " - 
Professor Roy L.Walford, M.D., UCLA School of Medicine, USA. 
   THE GERONTOLOGIST, 1991, vol.31, No.5, p.707. 
 
 
"CLEARLY,  THIS   IS   A   VERY   INTERESTING,   PROVOCATIVE   AND 
THOUGHT-PROVOKING BOOK" - Dr. Ward  Dean,  M.D.,  The  Center  for 
Bio-Gerontology,  Pencasola,  Florida,  USA. 
   EXPERIMENTAL GERONTOLOGY, 1992, vol.27, No.2, pp.251-253. 
 
 
"THIS IS  AN  INTERESTING  BOOK,  FULL  OF  TABLES  AND  DATA  AND 
POLEMICAL IN ITS APPROACH." - Professor William A.Pryor,  Director 
of Biodynamic Institute, Louisiana State University, Baton  Rouge, 
LA,USA. 
   FREE RADICAL BIOLOGY & MEDICINE, 1992, vol.12, pp.331-332. 
 
"IT BRINGS TO BEAR A FRESH  APPROACH  WHOSE  IDEAS  ARE  LOGICALLY 
PRESENTED AND DEVELOPED". - Dr. Brian Merry, Ph.D., Institute  of 
Human  Aging, University of Liverpool, United Kingdom. 
   AGEING AND SOCIETY, 1991, vol.11, No.4, pp.509-510. 
 
 
"GOOD NEW BOOK ON AGEING". - Dr. Thomas B.L.Kirkwood, Ph.D. 
Head of the Laboratory of Mathematical Biology, National
Institute for Medical Research, London, United Kingdom. 
   NATURE, 1991, vol.352, 29 August, pp.767-768. 
 
  
"... SHOULD BE READ BY ANYONE SERIOUSLY INTERESTED IN AGEING.  ... 
YOU WILL FIND THIS A SURPRISINGLY GOOD  'READ',  AND  A  MUST  FOR 
EVERY  LIBRARY".  -  Dr.   D.Sebastian   Fairweather,   Physician, 
   Department of Geriatric Medicine, Oxford, United Kingdom. 
   AGE AND AGEING, 1992, vol.21, No.5, pp.386-387. 
 
 
"THE BOOK FEATURES QUITE A BIT OF DEMOGRAPHIC THEORY AND ANALYSIS. 
... IT IS REFRESHING"  -  Professor Michael R.Rose, University  of 
   California, Irvine, USA. 
   ANNALS OF HUMAN BIOLOGY, 1992, vol.19, No.3, pp.320-321. 
  
 
"THE GAVRILOVS HAVE MADE A VALUABLE CONTRIBUTION TO THE  STUDY  OF 
LIFE SPAN, AND ANY FUTURE WORK ON THE SUBJECT WILL  HAVE  TO  TAKE 
ACCOUNT OF THE RICH CONTENTS OF THIS BOOK". - Dr. Vaino Kannisto, 
Former United Nations Adviser on Demography 
   POPULATION STUDIES, 1992, vol.46, No.2, pp. 366-367. 
   
"EIN AKTUELLES BUCH, DAS SICHERLICH DIE INTERNATIONALE 
DISKUSSION DES PROBLEMS BEFORDERN KANN." 
 - Prof. Dr. Ingeborg Falck, Berlin, Germany. 
   ZEITSCHRIFT FUR GERONTOLOGIE, 1991, Band 25, Heft 1, S.56. 
 
 
"THE BOOK IS WELL WRITTEN, EASY TO READ, AND SHOULD BE OF INTEREST 
TO A WIDE SPECTRUM OF READERS  INCLUDING  PHYSICIANS,  BIOLOGISTS, 
BIOCHEMISTS, GERONTOLOGISTS..." 
 - Prof. Robert W.Gracy, University of North Texas, USA. 
   EDUCATIONAL GERONTOLOGY, 1993, vol.19, No.1, pp.92-93. 
 
"...  THIS  BOOK  IS  A  HIGHLY  VALUABLE  CONTRIBUTION   TO   THE 
DISCIPLINE. ...THIS BOOK SHOULD MAKE  SCIENTISTS  TAKE  NOTICE  OF 
RESEARCH ON AGING AND LONGEVITY ... IN THE FORMER SOVIET UNION" - 
    Dr.  S.Jay Olshansky, Ph.D., University of Chicago, USA  
POPULATION AND DEVELOPMENT REVIEW, 1992, vol.18, No.3, pp.555-558.
 
"... MANY WILL FIND AN EXCURSION INTO IT STIMULATING". 
 - Dr. Emily Grundy, Lecturer in Gerontology, Age Concern 
   Institute of Gerontology, King's College, London, UK. 
   BRITISH MEDICAL JOURNAL, 1992, vol.305, No.6850, p.431. 
 
"GAVRILOV MAKES THE BEST ATTEMPT I KNOW OF TO DISTINGUISH HOW LONG 
PEOPLE COULD LIVE FROM HOW LONG THEY ACTUALLY LIVE -  ONE  OF  THE 
MORE DIFFICULT TASKS FOR BOTH BIOLOGY AND STATISTICS... GAVRILOV'S 
SCHOLARSHIP  IS   IMPRESSIVE".   -   Professor   Nathan   Keyfitz, 
   International   Institute   for   Applied   Systems   Analysis, 
   Laxenburg, Austria.
   MATHEMATICAL POPULATION STUDIES, 1991, vol.3, No.2, p.161. 
                                                            
"LEONID  GAVRILOV   IS   A   TOP-FLIGHT   STATISTICAL   POPULATION 
BIOLOGIST... THE AREA IS IMPORTANT WELL  BEYOND  THE  CONFINES  OF 
BIOLOGICAL  GERONTOLOGY  AND  EXTENDS  INTO  POLITICS  AND  SOCIAL 
PLANNING. GAVRILOV IS VERY GOOD ON JUST THIS SORT OF THING. HE HAS 
A FRESH APPROACH, NEW IDEAS, A GREAT  DEAL  OF  DATA  NOT  READILY 
AVAILABLE ELSEWHERE." - Roy. L. Walford, Professor  of  Pathology, 
   UCLA School of Medicine, USA. 
   MATHEMATICAL POPULATION STUDIES, 1991, vol.3, No.2, p.161. 
 
  
"THIS  BOOK  IS  DIRECTED   TOWARD   RESEARCHERS   INTERESTED   IN 
STATISTICAL PATTERNS AND MATHEMATICAL MODELS OF HUMAN  LIFE  SPAN. 
FOR STUDENTS WITHIN THIS  DEFINED  AREA  OF  RESEARCH,  THIS  TEXT 
OFFERS A GOOD HISTORICAL PERSPECTIVE,  INSIGHT  INTO  THE  RUSSIAN 
LITERATURE, AND INSIGHT INTO THE  QUANTITATIVE  ANALYSIS  OF  LIFE 
SPAN"   -   Dr.  Deborah  A.Roach,  Department  of  Zoology, 
    Duke University, Durham, USA. 
    ECOLOGY, 1992, vol.73, No.1, pp.379-381. 
 
 
"THIS BOOK IS IN ESSENCE A BIOSTATISTICAL ANALYSIS OF THE PROBLEMS 
OF  LIFESPAN,  HUMAN  AND  ANIMAL.  ...  THE  LITERATURE  IN  MANY 
LANGUAGES HAD CLEARLY BEEN WELL COVERED, AND MUCH HAS BEEN MADE OF 
NATIONAL AND OTHER MORTALITY STATISTICS IN  THIS  CENTURY.  ... 
A USEFUL SOURCE BOOK." - Dr. F.I.Caird, D.M., F.R.C.P.,  Professor 
   of Geriatric Medicine, Southern General Hospital, Glasgow, UK.
   J. OF CLINICAL AND EXPERIMENTAL GERONTOLOGY, 1992, vol.14, 
   No. 3 & 4, p.309. 
 
"... THE READER WILL BENEFIT ENORMOUSLY  FROM  THE  BROADENING  OF 
PERSPECTIVE AS A RESULT OF EXPOSURE TO THE GAVRILOVS' THEORIES  ON 
THE BIOLOGY OF LIFE SPAN"    -   Dr. M. Michael  Akiyama, 
   University of Michigan, Dearborn, USA. 
   HUMAN BIOLOGY, 1992, vol.64, No.4, pp.630-632. 
 
 
"THIS IS A PROVOCATIVE AND REFRESHING BOOK" - Dr.Alan R.Hipkiss, 
   Age Concern Institute of Gerontology, King's College London, UK. 
 INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1992, vol.7,No.8,p.614. 
 
 
"THIS BOOK SHOULD  BE  READ  BY  ALL  MEMBERS  OF  THE  PROFESSION 
INTERESTED IN MORTALITY - WHICH  SHOULD  BE  ALL  MEMBERS  OF  THE 
PROFESSION" -  Dr. H.A.R.Barnett, Institute of Actuaries, UK. 
 J.OF THE INSTITUTE OF ACTUARIES, 1992, vol.119, Part II, pp.379-381.
 
"TO SUM UP, THE BOOK IS SUBSTANTIAL, INTERESTING AND BRINGS  FRESH 
AIR. WE CAN CONFIDENTLY COMMEND ITS STUDY TO ALL SCIENTISTS ... " 
   - Dr. Janos Izsak, Department of Zoology, Berzsenyi Teachers' 
   College, Szombathely, Hungary. 
ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1992, vol.15, No.2,pp.192-194.
 
"A GENERAL THEORY OF LIFESPAN IS THUS CREATED." - 
 - Dr. Norman Vetter, University Hospital of Wales, Cardiff, UK. 
J.OF EPIDEMIOLOGY & COMMUNITY HEALTH, 1992, vol.46, No.6, p.630. 
 
"I FOUND IT TO BE HIGHLY REWARDING READING." -  
   Dr. Edward J.Masoro, University of Texas Health Science Center.
   QUARTERLY REVIEW OF BIOLOGY, 1993, vol.68, p.92. 
 
 
"THIS ... IS AN EXCELLENT BOOK. ... NOBODY INTERESTED IN AGING SHOULD   
FAIL TO READ". - 
   Dr. C.S.Downes, Department of Zoology, University of Cambridge, UK. 
   BIOESSAYS, 1993, vol.15, No.5, pp.359-362. 


"...PROVOCATIVE AND ENTERTAINING READING AND CAN BE RECOMMENDED TO 
ANYONE WITH AN INTEREST IN BIOLOGICAL AGING." - 
   Dr. Douglas E.Crews, Department of Anthropology, Ohio State 
   University, USA
   JOURNAL OF CROSS-CULTURAL GERONTOLOGY, 1993, vol.8, No.3, pp.281-290.


"IT DESERVES TO BE READ WIDELY. SCIENTISTS AND PHYSICIANS WHO ARE 
INTERESTED IN THE AGING OF POPULATIONS OR OF INDIVIDUALS WILL BE MUCH 
MORE EFFECTIVE IN THEIR WORK IF THEY BECOME FAMILIAR WITH THE SUBJECT 
MATTER OF THIS BOOK." - 
    JOURNAL OF ORTHOMOLECULAR MEDICINE, 1993, vol.8, No.1, pp.59-60. 
*********************************THE END************************************


From owner-ageing@net.bio.net Sun Apr 24 23:00:00 1994
Path: biosci!daresbury!trane.uninett.no!eunet.no!nuug!EU.net!howland.reston.ans.net!europa.eng.gtefsd.com!library.ucla.edu!csulb.edu!paris.ics.uci.edu!news.claremont.edu!nntp-server.caltech.edu!mac9.bio.caltech.edu!user
From: grovesa@starbase1.caltech.edu (Andrew K. Groves)
Newsgroups: bionet.molbio.ageing
Subject: Re: Hayflick limit wrong ?
Followup-To: bionet.molbio.ageing
Date: 25 Apr 1994 21:22:41 GMT
Organization: California Institute of Technology
Lines: 66
Distribution: bionet
Message-ID: <grovesa-250494141515@mac9.bio.caltech.edu>
References: <2pgrb1$p2o@mserv1.dl.ac.uk>
NNTP-Posting-Host: mac9.bio.caltech.edu

In article <2pgrb1$p2o@mserv1.dl.ac.uk>, "Leonid Gavrilov"
<gavrilov@aeiveos.uucp.free.msk.su> wrote:

> 
> 
> Dear AGEING LIST subscribers,
> 
>    I would like to know the current situation for the discovery of the 
> authors mentioned below, that simple change of composition of the cell 
> culture medium could eliminate cellular senescence: 
> 
>     Loo, D.T., Fuquay, J.I., Rawson, C.L. and Barnes, D.W. (1987). 
> Extended culture of mouse embryo cells without senescence: inhibition by 
> serum. Science 236, 200-202. 
> 
>    These authors demonstrated that normal diploid mouse embryo cells, which 
> under standard conditions manifest a growth crisis after 7-10 population 
> doublings, may be successfully cultivated without any sign of an 
> approaching growth crisis for at least 200 population doublings. All that is 
> necessary is to change the composition of the culture medium (excluding 
> blood serum and adding a number of ingredients, including the epidermal 
> growth factor). In this case the cells, which are apparently capable of 
> unlimited multiplication, remain diploid and nontumorigenic.
> 
>    If that is true, then the claim of Dr.Hayflick that all diploid cells 
> have intrinsic limit to cell division, is definitely wrong. 
> 
>    Does anybody know whether the results of these authors were reproduced 
> or disproved ?  
>

Leonid,

That paper hasn't been 'disproved' as such, but the findings have been put
in a different perspective. In 1990 David Barnes' group published another
paper showing that the cells referred to in their Science paper could be
induced to express GFAP (glial fibrillary acidic protein) in the presence
of serum or TGF-beta. The reference is Sakai et al., PNAS 87 8378-8392.

In the original Science paper, I believe the authors simply took mouse
embryo carcasses (including the head and spinal cord) and grew them in
their defined medium. In the light of the induction of GFAP, it would
appear that what they were growing were not fibroblasts (as in the Hayflick
and Moorhead work), but rather astrocyte precursors.

There are quite a few reports of precursor cells being able to proliferate
for long periods of time in defined medium containing growth factors. For
example, Reynolds and Weiss (Science 255, 1707-1710, 1992) could grow a
neural precursor cell for long periods in EGF. Bogler et al. (PNAS 87
6368-6372, 1990) were able to grow oligodendrocyte-type-2 astrocyte
progenitor cells in PDGF and FGF for many months.

I have often wondered what results the Barnes group would have obtained if
they had removed the nervous tissue from their mouse embryos. To my
knowledge, there is no data to suggest that fibroblasts can be cultivated
in defined medium indefinitely without transformation - although I would be
happy to be proved wrong.

I hope this is helpful.

Andy

--
Andy Groves
Division of Biology, 216-76
California Institute of Technology

From owner-ageing@net.bio.net Mon Apr 25 23:00:00 1994
Path: biosci!agate!howland.reston.ans.net!EU.net!uknet!daresbury!not-for-mail
From: Sydney Shall <S.Shall@sussex.ac.uk>
Newsgroups: bionet.molbio.ageing
Subject: Infinite growth of normal cells in serum-free medium
Date: 26 Apr 1994 09:46:09 +0100
Lines: 66
Sender: daemon@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <2pikch$nbo@mserv1.dl.ac.uk>
Original-To: ageing@dl.ac.uk

	There has been a query from Leonid Gavrilov concerning the
report from D. W. Barnes et al., that mouse cells have an infinite
life span in serum free medium. 

	I understand that the Barnes group have found that this
observation can not be reproduced with human cells.

	Clearly therefore the limit on life-span of normal human
cells ( the Hayflick phenomenon still exists).

	The explanation for the obsevation made by Barnes et al., is
still unclear.  I am not aware of any published report confirming the
observation. Also as another correspondent has already written, it is
unclear whether the observation is explained by the absence of serum
or by the presence of particular cell types in the Barnes
experiments.  It amy be that they were looking at cell types which
differentiate in the presence of certain growth factors.  A more
interesting possibility to me, is that in the Barnes' experiment
there were primordial embryonic cells which are in fact immortal.
This is a distinct theorectical possibility because we know that germ
cells are really immortal.

	It is also possible that the observation made by the Barnes'
group was due, as they suggested, to the presence of serum.  It is
worth considering that the very long term presence of either
stimulatory or inhibitory growth factors is part of the molecular
causation of the limited life-span.  I think this is unlikely because
the life-span number is both tissue and species specific, and this
implies a genetic origin to me.  Moreover, and more convincingly, we
have shown that in the human progeria disease, Werner's syndrome,
which is a single Mendelian locus disease, there is a change in the
length of the life-span of human fibroblasts.

	A repetition of the observation made by Barnes and coworkers
and an exploration of this result would be very worthwhile.

**************************************************************************

**************************************************************************



Sydney SHALL,
Laboratory of Cell and Molecular Biology,
Biology Building,
University of Sussex,
Brighton,
East Sussex BN1 9QG,
ENGLAND.

Telephone: +44.273.67.83.03

FAX: +44.273.67.84.33

E-Mail:

	Janet:		S.Shall@uk.ac.sussex

	Elsewhere:	S.Shall@sussex.ac.uk

	EARN/BITNET:	S.Shall%sussex@ukacrl


*******************************************************************************   

*******************************************************************************

From owner-ageing@net.bio.net Tue Apr 26 23:00:00 1994
Path: biosci!agate!howland.reston.ans.net!EU.net!sunic!ugle.unit.no!trane.uninett.no!daresbury!not-for-mail
From: "Leonid Gavrilov" <gavrilov@aeiveos.uucp.free.msk.su>
Newsgroups: bionet.molbio.ageing
Subject: JOIN OUR RESEARCH TEAM !
Date: 27 Apr 1994 12:28:54 +0100
Organization: A.N.Belozersky Institute, Moscow State University
Lines: 74
Sender: daemon@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <2pli9m$j0u@mserv1.dl.ac.uk>
X-Russian: Cyrillic
Original-To: AGEING@dl.AC.UK



April 27, 1994

Dear AGEING LIST subscribers !

   The purpose of this message is to invite you to join a research 
team for receiving EC grant called COPERNICUS. 

   In order to receive this grant a team of 5 researchers from 
5 different countries should be created: 2 researchers from EC countries, 
2 researchers from Eastern European countries and 1 researcher from 
the countries of the former Soviet Union (myself). Additional researchers 
from other eligible countries are very much wellcome.

   The suggested topic of the grant is:
 
   PARENTAL AGE AND OFFSPRING LONGEVITY

   The members of the team are: 

1) Professor F.A. Lints <lints@gena.ucl.ac.be>
   Unite de Genetique
   Universite catholique de Louvain
   Place Croix-du-Sud, 2 bte 14
   B-1348 Louvain-la-Neuve
   Belgique

   tel 32-10-47.36.67
   fax 32-10-47.30.31


2) Dr. Leonid A.Gavrilov, Ph.D. <aeiveos@glas.apc.org>
   A.N.Belozersky Institute
   Moscow State University
   119899 Moscow, RUSSIA
   FAX: 7 (095) 939-0338 or 7 (095) 939-3181
   tel.: 7 (095) 427-0047

3) Dr. Eric Lebourg (Toulouse, France)

   Thus, we should find 2 additional partners from 2 different countries
of the Eastern Europe: Albania, Bulgaria, Checkia, Estonia, Hungary,
Latvia, Lithuania, Poland, Romania, Slovakia and Slovenia.

   WE ARE KINDLY INVITING RESEARCHERS FROM THE ABOVE MENTIONED COUNTRIES 
TO CONTACT US (BOTH ME AND PROFESSOR LINTS) AS SOON AS POSSIBLE !

   The deadline for application is May 2, 1994. So, we are to be very rapid !

   Sincerely yours,

   Dr.Leonid A.Gavrilov, Ph.D.
   Member of the New York Academy of Sciences

P.S.: My CV is available upon the request or could be extracted from 
archives of AGEING LIST (message 447 of April 23). 
-- 

________________________________________________________________
-- Dr. Leonid A. Gavrilov, Ph.D.   Phone: 7 (095) 427 0047 
   Principal Research Scientist    FAX: 7 (095) 939 0338 or 
   A.N.Belozersky Institute             7 (095) 939 3181 
   Moscow State University         E-mail addresses: 
   Moscow 119899                   gavrilov@aeiveos.uucp.free.msk.su   
   Russia                             libro@genebee.msu.su
                                    aeiveos@glas.apc.org

   Please send your answer to my most reliable E-mail address:

                     aeiveos@glas.apc.org

   if you wish to be sure to reach me. Thank you !
___________________________________________________________________

From owner-ageing@net.bio.net Tue Apr 26 23:00:00 1994
Path: biosci!agate!howland.reston.ans.net!noc.near.net!das-news.harvard.edu!husc-news.harvard.edu!husc.harvard.edu!husc8.harvard.edu!gwmartin
Newsgroups: bionet.molbio.ageing
Subject: Re: Telomerase
Message-ID: <2plpkd$p12@scunix2.harvard.edu>
From: gwmartin@husc8.harvard.edu (glover martin)
Date: 27 Apr 1994 13:34:05 GMT
References: <2pg1c8$kbu@infa.central.susx.ac.uk>
Organization: Harvard University, Cambridge, Massachusetts
NNTP-Posting-Host: husc8.harvard.edu
X-Newsreader: TIN [version 1.2 PL1]
Lines: 45

Sydney Shall (bafa1@central.susx.ac.uk) wrote:
: 	The enzyme telomerase has been shown to be present in immortal
: cell lines.  However, it has never been purified and therefore it has
: never been cloned.

Yeast telomeres were first cloned in 1982 (Szostak & Blackburn; Cell 
29:245).  Tetrahymena telomerase was cloned in 1987 
(Greider & Blackburn; Cell 51: 887) and I suspect a mammalian homologue 
has since been cloned.  Telomerase turns out to be a protein which contains 
a small RNA molecule, used to prime telomere synthesis.



: 	The average length of telomeres in dividing normal,
: untransformed cells has been shown to shorten as the cell culture ages. 

True.  And Lundblad & Szostak (1989) showed that in yeast, defects in 
telomere elongation correlates with senescence.

: That is, there is a correlation between the length of the average
: telomere size and the age of the culture.

: 	The predictions of what the re-introduction of a telomerase
: enzyme might do in ageing cells requires the cloning of the gene for
: this enzyme.  This is proving a very difficult task.

: 	In presence it should be possible to reactivate the expression
: of this gene in normal cells, and to repress its expression in cancer
: cells, but this also awaits the cloning of the gene.

But, only actively dividing cells would really have a need for 
telomerase, right?  I don't know how many cell types, besides epithelial 
and hematopoietic cells, aren't terminally differentiated in adults.  
However, part of the problem with transformed cells is that they do not 
senesce (sp?), like you imply.  But I wonder if maintenace of telomere 
integrity isn't part of some greater cellular aging program.  In that 
case, turning on telomerase in cancer cells may not have the desired effect.

: 	This area is therefore both very active and very excitibg, and
: there is lots of room for more people in this field.

I agree.

Trei


From owner-ageing@net.bio.net Tue Apr 26 23:00:00 1994
Path: biosci!daresbury!not-for-mail
From: "Leonid Gavrilov" <gavrilov@aeiveos.uucp.free.msk.su>
Newsgroups: bionet.molbio.ageing
Subject: Parental Age and Offspring Longevity
Date: 27 Apr 1994 18:03:39 +0100
Organization: A.N.Belozersky Institute, Moscow State University
Lines: 74
Sender: daemon@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <2pm5tb$p7n@mserv1.dl.ac.uk>
X-Russian: Cyrillic
Original-To: AGEING@dl.AC.UK



April 27, 1994

Dear AGEING LIST subscribers !

   The purpose of this message is to invite you to join a research 
team for receiving EC grant called COPERNICUS. 

   In order to receive this grant a team of 5 researchers from 
5 different countries should be created: 2 researchers from EC countries, 
2 researchers from Eastern European countries and 1 researcher from 
the countries of the former Soviet Union (myself). Additional researchers 
from other eligible countries are very much wellcome.

   The suggested topic of the grant is:
 
   PARENTAL AGE AND OFFSPRING LONGEVITY

   The members of the team are: 

1) Professor F.A. Lints <lints@gena.ucl.ac.be>
   Unite de Genetique
   Universite catholique de Louvain
   Place Croix-du-Sud, 2 bte 14
   B-1348 Louvain-la-Neuve
   Belgique

   tel 32-10-47.36.67
   fax 32-10-47.30.31


2) Dr. Leonid A.Gavrilov, Ph.D. <aeiveos@glas.apc.org>
   A.N.Belozersky Institute
   Moscow State University
   119899 Moscow, RUSSIA
   FAX: 7 (095) 939-0338 or 7 (095) 939-3181
   tel.: 7 (095) 427-0047

3) Dr. Eric Lebourg (Toulouse, France)

   Thus, we should find 2 additional partners from 2 different countries
of the Eastern Europe: Albania, Bulgaria, Checkia, Estonia, Hungary,
Latvia, Lithuania, Poland, Romania, Slovakia and Slovenia.

   WE ARE KINDLY INVITING RESEARCHERS FROM THE ABOVE MENTIONED COUNTRIES 
TO CONTACT US (BOTH ME AND PROFESSOR LINTS) AS SOON AS POSSIBLE !

   The deadline for application is May 2, 1994. So, we are to be very rapid !

   Sincerely yours,

   Dr.Leonid A.Gavrilov, Ph.D.
   Member of the New York Academy of Sciences

P.S.: My CV is available upon the request or could be extracted from 
archives of AGEING LIST (message 447 of April 23). 
-- 

________________________________________________________________
-- Dr. Leonid A. Gavrilov, Ph.D.   Phone: 7 (095) 427 0047 
   Principal Research Scientist    FAX: 7 (095) 939 0338 or 
   A.N.Belozersky Institute             7 (095) 939 3181 
   Moscow State University         E-mail addresses: 
   Moscow 119899                   gavrilov@aeiveos.uucp.free.msk.su   
   Russia                             libro@genebee.msu.su
                                    aeiveos@glas.apc.org

   Please send your answer to my most reliable E-mail address:

                     aeiveos@glas.apc.org

   if you wish to be sure to reach me. Thank you !
___________________________________________________________________

From owner-ageing@net.bio.net Tue Apr 26 23:00:00 1994
Path: biosci!agate!ihnp4.ucsd.edu!swrinde!cs.utexas.edu!howland.reston.ans.net!pipex!uknet!daresbury!not-for-mail
From: "Leonid Gavrilov" <gavrilov@aeiveos.uucp.free.msk.su>
Newsgroups: bionet.molbio.ageing
Subject: Grant for Eastern European scientists
Date: 27 Apr 1994 18:07:19 +0100
Organization: A.N.Belozersky Institute, Moscow State University
Lines: 74
Sender: daemon@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <2pm647$pd5@mserv1.dl.ac.uk>
X-Russian: Cyrillic
Original-To: AGEING@dl.AC.UK



April 27, 1994

Dear AGEING LIST subscribers !

   The purpose of this message is to invite you to join a research 
team for receiving EC grant called COPERNICUS. 

   In order to receive this grant a team of 5 researchers from 
5 different countries should be created: 2 researchers from EC countries, 
2 researchers from Eastern European countries and 1 researcher from 
the countries of the former Soviet Union (myself). Additional researchers 
from other eligible countries are very much wellcome.

   The suggested topic of the grant is:
 
   PARENTAL AGE AND OFFSPRING LONGEVITY

   The members of the team are: 

1) Professor F.A. Lints <lints@gena.ucl.ac.be>
   Unite de Genetique
   Universite catholique de Louvain
   Place Croix-du-Sud, 2 bte 14
   B-1348 Louvain-la-Neuve
   Belgique

   tel 32-10-47.36.67
   fax 32-10-47.30.31


2) Dr. Leonid A.Gavrilov, Ph.D. <aeiveos@glas.apc.org>
   A.N.Belozersky Institute
   Moscow State University
   119899 Moscow, RUSSIA
   FAX: 7 (095) 939-0338 or 7 (095) 939-3181
   tel.: 7 (095) 427-0047

3) Dr. Eric Lebourg (Toulouse, France)

   Thus, we should find 2 additional partners from 2 different countries
of the Eastern Europe: Albania, Bulgaria, Checkia, Estonia, Hungary,
Latvia, Lithuania, Poland, Romania, Slovakia and Slovenia.

   WE ARE KINDLY INVITING RESEARCHERS FROM THE ABOVE MENTIONED COUNTRIES 
TO CONTACT US (BOTH ME AND PROFESSOR LINTS) AS SOON AS POSSIBLE !

   The deadline for application is May 2, 1994. So, we are to be very rapid !

   Sincerely yours,

   Dr.Leonid A.Gavrilov, Ph.D.
   Member of the New York Academy of Sciences

P.S.: My CV is available upon the request or could be extracted from 
archives of AGEING LIST (message 447 of April 23). 
-- 

________________________________________________________________
-- Dr. Leonid A. Gavrilov, Ph.D.   Phone: 7 (095) 427 0047 
   Principal Research Scientist    FAX: 7 (095) 939 0338 or 
   A.N.Belozersky Institute             7 (095) 939 3181 
   Moscow State University         E-mail addresses: 
   Moscow 119899                   gavrilov@aeiveos.uucp.free.msk.su   
   Russia                             libro@genebee.msu.su
                                    aeiveos@glas.apc.org

   Please send your answer to my most reliable E-mail address:

                     aeiveos@glas.apc.org

   if you wish to be sure to reach me. Thank you !
___________________________________________________________________

From owner-ageing@net.bio.net Fri Apr 29 23:00:00 1994
Path: biosci!agate!howland.reston.ans.net!EU.net!uknet!daresbury!not-for-mail
From: "Leonid Gavrilov" <gavrilov@aeiveos.uucp.free.msk.su>
Newsgroups: bionet.molbio.ageing
Subject: Funds for Eastern European scientists
Date: 30 Apr 1994 11:25:43 +0100
Organization: A.N.Belozersky Institute, Moscow State University
Lines: 358
Sender: daemon@mserv1.dl.ac.uk
Distribution: bionet
Message-ID: <2ptbn7$7st@mserv1.dl.ac.uk>
X-Russian: Cyrillic
Original-To: AGEING@dl.AC.UK



April 30, 1994

Dear subscribers,

   European Community allocated funds for international scientific 
collaboration of European scientists (program called COPERNICUS). 

   I am one of the coordinators of the research team of 5 scientists 
from 5 different European countries that will work on the project: 

            PARENTAL AGE AND OFFSPRING LONGEVITY

   We have room in our research group for scientists from the following 
countries: 

   Albania, Bulgaria, Checkia, Estonia, Latvia, Lithuania, Poland,
Romania, Slovakia and Slovenia
   
   We are kindly inviting the scientists from the above mentioned 
countries to join our research team and to send their CVs before 
the COPERNICUS deadline (May 2) to my E-mail address: 

                    aeiveos@glas.apc.org

   Thank you in advance for your kindness.

   Sincerely yours, 

   Dr.Leonid A.Gavrilov, Ph.D.
   Member of the New York Academy of Sciences

P.S.: My CV is printed below for introduction.
***************************************************************************
                                                     April 24, 1994
                                        
 
               C U R R I C U L U M    V I T A E  
 
Dr. Leonid A. Gavrilov, Ph.D.          Phone: 7 (095) 427 0047 
Principal Research Scientist           FAX: 7 (095) 939 0338 or 
A.N.Belozersky Institute                    7 (095) 939 3181 
Moscow State University                E-mail addresses: 
Moscow 119899                          libro@genebee.msu.su 
Russia                             gavrilov@aeiveos.uucp.free.msk.su
                                        aeiveos@glas.apc.org 
 
Date of Birth: August 28, 1954 
Place of Birth: USSR (Russia), town of Sverdlovsk (now Ekaterinburg) 
Research interests: Mechanisms of ageing, age-related mortality,         
                    longevity. 
 
Education: 
   Ph.D. - Moscow State University (1980) in mortality kinetics 
           in human populations and animal models, with emphasis 
           on mathematical models of mortality. 
   M.Sc. - Moscow State University (1976) in mechanisms of aging 
           with emphasis on mathematical models of aging 
  
Professional Experience: 
 
1991-Present  Principal Research Scientist, A.N.Belozersky Institute, 
              Moscow State University. 
1987-1991   Senior Research Scientist, A.N.Belozersky Institute, 
            Moscow State University. 
1980-1987   Research Scientist, A.N.Belozersky Institute, 
            Moscow State University. 
 
Professional Activities and Other Positions:
   - Member of the New York Academy of Science (Member ID #364586)
   - Principal Investigator of the International Science Foundation
        Research Grant # M7E000.
   - Chairman of the Subsection of the Biology of Life Span at 
        Moscow Society of Naturalists (1981-1992).
   - Expert (book reviewer) for journals AGE AND AGEING, AGEING 
        AND SOCIETY, J.GENERAL BIOLOGY and Publishers "MIR". 
   - Expert (peer reviewer) for journals MATHEMATICAL POPULATION 
        STUDIES, J.GENERAL BIOLOGY. 
   - Chairperson of the Biological Session at the II European 
        Congress of Gerontology (Madrid, 1991). Certificate signed 
        by F.Guillen Llera, General Secretary of the Congress. 
   - Expert (book editor) for Institute of Scientific Information 
        (VINITI, Moscow). 
   - Fellow of Moscow Society of Naturalists.
   - Senior Research Scientist at the Russian Academy of Sciences 
        Institute for System Analysis. 
   - Scientific Secretary of Demographic Section of Moscow House 
        of Scientists (1984-1991). 
   - Fellow of the Moscow House of Scientists. 

Awards: 

   - International Science Foundation (ISF) 1994 Research Grant #M7E000.
   - International Science Foundation (ISF) 1993 Emergency Grant Award.
   - International Science Foundation (ISF) 1994 Emergency Grant for 
        Russian Scientists of the Top Category.
   - The Certificate from the International Association of Gerontology 
        (1993) signed by the President and the Secretary General of the 
        International Association of Gerontology. 
   - A.N.Belozersky Institute 1991 Award for the best scientific 
        research in the Institute in 1990-1991. 
   - Moscow Society of Naturalists 1989 Award for the best scientific 
        research in natural science in 1986-1988. 
   - Grant Award with invitation to European Population Conference 
        (Paris, October 1991). 
   - Financial Award with invitation of giving a lectures to Trinity 
        College, Cambridge University (December, 1991). 
   - Financial Award with invitation to the Annual Meeting of British 
        Biochemical Society (Southampton, April, 1992). 
  
Publications: 
65 publications, including 5 books.  Selected publications in the most 
prestigeous scientific peer reviewed journals are:
  
    - "Sex and Longevity", Nature, 1994, vol.367, No.6463, p.520.
    - "Fruit Fly Aging and Mortality", Science, 1993, vol.260, No.5114,
          p.1565. 
    - "When Your Time's Up", British Medical Journal, 1993, vol.306, 
          No.6880, p.796.
    - "Human Life Span Stopped Increasing: Why?", Gerontology, 1983,
          vol.29, pp.176-180. 
    - "Life Span is Determined by Resting Metabolic Rate of Parents 
          Only!", Age, 1989, vol.12, p.113. 
    - "Human Species-Specific Life-Span: Its Estimation and  
          Interpretation", Age, 1985, vol.8, p.94. 
    - "A New Trend in Human Mortality Decline: Derectangularization 
          of the Survival Curve", Age, 1985, vol.8, p.93. 
    - "Biology of Aging (Book Review)", Age and Ageing, 1993, vol.22,
          pp.233-234. 
   - "Evolutionary Biology of Aging (Book Review)", Ageing and 
          Society, 1992, vol.12, No.4, pp.539-541. 
    - "How Many Cell Divisions in 'Old' Cells?", International Journal 
          of Geriatric Psychiatry, 1993, vol.8, No.6, p.528. 
    - "Common Sense and the Limits to Life", International Journal of 
          Geriatric Psychiatry, 1993, vol.8, No.8, p.695. 
    - "Historically Stable Indices of Mortality and their Use for 
          Medical Geography", Geographia Medica, 1984, vol.14, 
          pp.305-306. 
    - "Epidemiologic Approach to the Biology of Human Life Span", 
          Geographia Medica, 1985, vol.15, pp.40-64. 

    The key publication where the main results of the previous studies 
are summarised is: 

        THE BIOLOGY OF LIFE SPAN: A QUANTITATIVE APPROACH.        

By Leonid A.Gavrilov and Natalia S.Gavrilova. Harwood  Academic 
Publishers: 1991. Pp. 385, $ 120, ISBN 3-7186-4983-7.

   Positive reviews of this book were published by  the  following 
journals: 

 1. AGE AND AGEING, 1992, vol.21, No.5, pp.386-387. 
 2. AGEING AND SOCIETY, 1991, vol.11, No.4, pp.509-510.
 3. ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1992, vol.15, No.2, pp.192-194. 
 4. ARGOMENTI DI GERONTOLOGIA, 1993, vol.5, No.2, p.91.
 5. BIOESSAYS, 1993, vol.15, No.5, pp.359-362. 
 6. BOLLETTINO DELLA SOCIETA ITALIANA DI GERONTOLOGIA E GERIATRIA, 1992, 
    No.7, p.1.
 7. BRITISH MEDICAL JOURNAL, 1992, vol.305, No.6850, p.431. 
 8. EDUCATIONAL GERONTOLOGY, 1993, vol.19, No.1, pp.92-93. 
 9. EXPERIMENTAL GERONTOLOGY, 1992, vol.27, pp.251-253. 
10. FREE RADICAL BIOLOGY & MEDICINE, 1992, vol.12, pp.331-332. 
11. GERONTOLOGIST, 1991, vol.31, No.5, p.707.
12. HUMAN BIOLOGY, 1992, vol.64, No.4, pp.630-632.  
13. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1992, vol.7, No.8, p.614. 
14. JOURNAL OF CROSS-CULTURAL GERONTOLOGY, 1993, vol.8, No.3, pp.281-290.
15. JOURNAL OF EPIDEMIOLOGY & COMMUNITY HEALTH, 1992, vol.46, No.6, p.630. 
16. JOURNAL OF THE INSTITUTE OF ACTUARIES, 1992, vol.119, Part II, 
    pp.379-381. 
17. JOURNAL OF ORTHOMOLECULAR MEDICINE, 1993, vol.8, No.1, pp.59-60. 
18. NATURE, 1991, vol.352, 29 August, pp.767-768. 
19. POPULATION AND DEVELOPMENT REVIEW, 1992, vol.18, No.3, pp.555-558.
20. POPULATION STUDIES, 1992, vol.46, No.2, pp.366-367. 
21. QUARTERLY REVIEW OF BIOLOGY, 1993, vol.68, p.92. 
22. STATISZTIKAI SZEMLE (STATISTICAL REVIEW, In Hungarian), 
    1992,vol.70,No.6,pp.546-547.


Response of the Leading Scientists to the Scientific Research  and 
the Book by L.A.Gavrilov: 
 
"HIGHLY RECOMMENDED FOR STIMULATING FRESH APPROACHES ... " - 
Professor Roy L.Walford, M.D., UCLA School of Medicine, USA. 
   THE GERONTOLOGIST, 1991, vol.31, No.5, p.707. 
 
 
"CLEARLY,  THIS   IS   A   VERY   INTERESTING,   PROVOCATIVE   AND 
THOUGHT-PROVOKING BOOK" - Dr. Ward  Dean,  M.D.,  The  Center  for 
Bio-Gerontology,  Pencasola,  Florida,  USA. 
   EXPERIMENTAL GERONTOLOGY, 1992, vol.27, No.2, pp.251-253. 
 
 
"THIS IS  AN  INTERESTING  BOOK,  FULL  OF  TABLES  AND  DATA  AND 
POLEMICAL IN ITS APPROACH." - Professor William A.Pryor,  Director 
of Biodynamic Institute, Louisiana State University, Baton  Rouge, 
LA,USA. 
   FREE RADICAL BIOLOGY & MEDICINE, 1992, vol.12, pp.331-332. 
 
"IT BRINGS TO BEAR A FRESH  APPROACH  WHOSE  IDEAS  ARE  LOGICALLY 
PRESENTED AND DEVELOPED". - Dr. Brian Merry, Ph.D., Institute  of 
Human  Aging, University of Liverpool, United Kingdom. 
   AGEING AND SOCIETY, 1991, vol.11, No.4, pp.509-510. 
 
 
"GOOD NEW BOOK ON AGEING". - Dr. Thomas B.L.Kirkwood, Ph.D. 
Head of the Laboratory of Mathematical Biology, National
Institute for Medical Research, London, United Kingdom. 
   NATURE, 1991, vol.352, 29 August, pp.767-768. 
 
  
"... SHOULD BE READ BY ANYONE SERIOUSLY INTERESTED IN AGEING.  ... 
YOU WILL FIND THIS A SURPRISINGLY GOOD  'READ',  AND  A  MUST  FOR 
EVERY  LIBRARY".  -  Dr.   D.Sebastian   Fairweather,   Physician, 
   Department of Geriatric Medicine, Oxford, United Kingdom. 
   AGE AND AGEING, 1992, vol.21, No.5, pp.386-387. 
 
 
"THE BOOK FEATURES QUITE A BIT OF DEMOGRAPHIC THEORY AND ANALYSIS. 
.... IT IS REFRESHING"  -  Professor Michael R.Rose, University  of 
   California, Irvine, USA. 
   ANNALS OF HUMAN BIOLOGY, 1992, vol.19, No.3, pp.320-321. 
  
 
"THE GAVRILOVS HAVE MADE A VALUABLE CONTRIBUTION TO THE  STUDY  OF 
LIFE SPAN, AND ANY FUTURE WORK ON THE SUBJECT WILL  HAVE  TO  TAKE 
ACCOUNT OF THE RICH CONTENTS OF THIS BOOK". - Dr. Vaino Kannisto, 
Former United Nations Adviser on Demography 
   POPULATION STUDIES, 1992, vol.46, No.2, pp. 366-367. 
   
"EIN AKTUELLES BUCH, DAS SICHERLICH DIE INTERNATIONALE 
DISKUSSION DES PROBLEMS BEFORDERN KANN." 
 - Prof. Dr. Ingeborg Falck, Berlin, Germany. 
   ZEITSCHRIFT FUR GERONTOLOGIE, 1991, Band 25, Heft 1, S.56. 
 
 
"THE BOOK IS WELL WRITTEN, EASY TO READ, AND SHOULD BE OF INTEREST 
TO A WIDE SPECTRUM OF READERS  INCLUDING  PHYSICIANS,  BIOLOGISTS, 
BIOCHEMISTS, GERONTOLOGISTS..." 
 - Prof. Robert W.Gracy, University of North Texas, USA. 
   EDUCATIONAL GERONTOLOGY, 1993, vol.19, No.1, pp.92-93. 
 
"...  THIS  BOOK  IS  A  HIGHLY  VALUABLE  CONTRIBUTION   TO   THE 
DISCIPLINE. ...THIS BOOK SHOULD MAKE  SCIENTISTS  TAKE  NOTICE  OF 
RESEARCH ON AGING AND LONGEVITY ... IN THE FORMER SOVIET UNION" - 
    Dr.  S.Jay Olshansky, Ph.D., University of Chicago, USA  
POPULATION AND DEVELOPMENT REVIEW, 1992, vol.18, No.3, pp.555-558.
 
"... MANY WILL FIND AN EXCURSION INTO IT STIMULATING". 
 - Dr. Emily Grundy, Lecturer in Gerontology, Age Concern 
   Institute of Gerontology, King's College, London, UK. 
   BRITISH MEDICAL JOURNAL, 1992, vol.305, No.6850, p.431. 
 
"GAVRILOV MAKES THE BEST ATTEMPT I KNOW OF TO DISTINGUISH HOW LONG 
PEOPLE COULD LIVE FROM HOW LONG THEY ACTUALLY LIVE -  ONE  OF  THE 
MORE DIFFICULT TASKS FOR BOTH BIOLOGY AND STATISTICS... GAVRILOV'S 
SCHOLARSHIP  IS   IMPRESSIVE".   -   Professor   Nathan   Keyfitz, 
   International   Institute   for   Applied   Systems   Analysis, 
   Laxenburg, Austria.
   MATHEMATICAL POPULATION STUDIES, 1991, vol.3, No.2, p.161. 
                                                            
"LEONID  GAVRILOV   IS   A   TOP-FLIGHT   STATISTICAL   POPULATION 
BIOLOGIST... THE AREA IS IMPORTANT WELL  BEYOND  THE  CONFINES  OF 
BIOLOGICAL  GERONTOLOGY  AND  EXTENDS  INTO  POLITICS  AND  SOCIAL 
PLANNING. GAVRILOV IS VERY GOOD ON JUST THIS SORT OF THING. HE HAS 
A FRESH APPROACH, NEW IDEAS, A GREAT  DEAL  OF  DATA  NOT  READILY 
AVAILABLE ELSEWHERE." - Roy. L. Walford, Professor  of  Pathology, 
   UCLA School of Medicine, USA. 
   MATHEMATICAL POPULATION STUDIES, 1991, vol.3, No.2, p.161. 
 
  
"THIS  BOOK  IS  DIRECTED   TOWARD   RESEARCHERS   INTERESTED   IN 
STATISTICAL PATTERNS AND MATHEMATICAL MODELS OF HUMAN  LIFE  SPAN. 
FOR STUDENTS WITHIN THIS  DEFINED  AREA  OF  RESEARCH,  THIS  TEXT 
OFFERS A GOOD HISTORICAL PERSPECTIVE,  INSIGHT  INTO  THE  RUSSIAN 
LITERATURE, AND INSIGHT INTO THE  QUANTITATIVE  ANALYSIS  OF  LIFE 
SPAN"   -   Dr.  Deborah  A.Roach,  Department  of  Zoology, 
    Duke University, Durham, USA. 
    ECOLOGY, 1992, vol.73, No.1, pp.379-381. 
 
 
"THIS BOOK IS IN ESSENCE A BIOSTATISTICAL ANALYSIS OF THE PROBLEMS 
OF  LIFESPAN,  HUMAN  AND  ANIMAL.  ...  THE  LITERATURE  IN  MANY 
LANGUAGES HAD CLEARLY BEEN WELL COVERED, AND MUCH HAS BEEN MADE OF 
NATIONAL AND OTHER MORTALITY STATISTICS IN  THIS  CENTURY.  ... 
A USEFUL SOURCE BOOK." - Dr. F.I.Caird, D.M., F.R.C.P.,  Professor 
   of Geriatric Medicine, Southern General Hospital, Glasgow, UK.
   J. OF CLINICAL AND EXPERIMENTAL GERONTOLOGY, 1992, vol.14, 
   No. 3 & 4, p.309. 
 
"... THE READER WILL BENEFIT ENORMOUSLY  FROM  THE  BROADENING  OF 
PERSPECTIVE AS A RESULT OF EXPOSURE TO THE GAVRILOVS' THEORIES  ON 
THE BIOLOGY OF LIFE SPAN"    -   Dr. M. Michael  Akiyama, 
   University of Michigan, Dearborn, USA. 
   HUMAN BIOLOGY, 1992, vol.64, No.4, pp.630-632. 
 
"THIS IS A PROVOCATIVE AND REFRESHING BOOK" - Dr.Alan R.Hipkiss, 
   Age Concern Institute of Gerontology, King's College London, UK. 
 INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 1992, vol.7,No.8,p.614. 
 
"THIS BOOK SHOULD  BE  READ  BY  ALL  MEMBERS  OF  THE  PROFESSION 
INTERESTED IN MORTALITY - WHICH  SHOULD  BE  ALL  MEMBERS  OF  THE 
PROFESSION" -  Dr. H.A.R.Barnett, Institute of Actuaries, UK. 
 J.OF THE INSTITUTE OF ACTUARIES, 1992, vol.119, Part II, pp.379-381.
 
"TO SUM UP, THE BOOK IS SUBSTANTIAL, INTERESTING AND BRINGS  FRESH 
AIR. WE CAN CONFIDENTLY COMMEND ITS STUDY TO ALL SCIENTISTS ... " 
   - Dr. Janos Izsak, Department of Zoology, Berzsenyi Teachers' 
   College, Szombathely, Hungary. 
ARCHIVES OF GERONTOLOGY AND GERIATRICS, 1992, vol.15, No.2,pp.192-194.
 
"A GENERAL THEORY OF LIFESPAN IS THUS CREATED." - 
 - Dr. Norman Vetter, University Hospital of Wales, Cardiff, UK. 
J.OF EPIDEMIOLOGY & COMMUNITY HEALTH, 1992, vol.46, No.6, p.630. 
 
"I FOUND IT TO BE HIGHLY REWARDING READING." -  
   Dr. Edward J.Masoro, University of Texas Health Science Center.
   QUARTERLY REVIEW OF BIOLOGY, 1993, vol.68, p.92. 
 
 
"THIS ... IS AN EXCELLENT BOOK. ... NOBODY INTERESTED IN AGING SHOULD   
FAIL TO READ". - 
   Dr. C.S.Downes, Department of Zoology, University of Cambridge, UK. 
   BIOESSAYS, 1993, vol.15, No.5, pp.359-362. 


"...PROVOCATIVE AND ENTERTAINING READING AND CAN BE RECOMMENDED TO 
ANYONE WITH AN INTEREST IN BIOLOGICAL AGING." - 
   Dr. Douglas E.Crews, Department of Anthropology, Ohio State 
   University, USA
   JOURNAL OF CROSS-CULTURAL GERONTOLOGY, 1993, vol.8, No.3, pp.281-290.


"IT DESERVES TO BE READ WIDELY. SCIENTISTS AND PHYSICIANS WHO ARE 
INTERESTED IN THE AGING OF POPULATIONS OR OF INDIVIDUALS WILL BE MUCH 
MORE EFFECTIVE IN THEIR WORK IF THEY BECOME FAMILIAR WITH THE SUBJECT 
MATTER OF THIS BOOK." - 
    JOURNAL OF ORTHOMOLECULAR MEDICINE, 1993, vol.8, No.1, pp.59-60. 

*********************************THE END******************************
-- 

________________________________________________________________
-- Dr. Leonid A. Gavrilov, Ph.D.   Phone: 7 (095) 427 0047 
   Principal Research Scientist    FAX: 7 (095) 939 0338 or 
   A.N.Belozersky Institute             7 (095) 939 3181 
   Moscow State University         E-mail addresses: 
   Moscow 119899                   gavrilov@aeiveos.uucp.free.msk.su   
   Russia                             libro@genebee.msu.su
                                    aeiveos@glas.apc.org

   Please send your answer to my most reliable E-mail address:

                     aeiveos@glas.apc.org

   if you wish to be sure to reach me. Thank you !
___________________________________________________________________

From owner-ageing@net.bio.net Sat Apr 30 23:00:00 1994
Path: biosci!internet!biosci!not-for-mail
From: kristoff (David Kristofferson)
Newsgroups: bionet.molbio.ageing
Subject: UNSUBSCRIBING, BIOSCI ARCHIVES, ADDRESS DATABASE & BIOSCI FAQ
Date: 1 May 1994 02:00:25 -0700
Organization: BIOSCI International Newsgroups for Molecular Biology
Lines: 275
Sender: daemon@net.bio.net
Distribution: bionet
Message-ID: <199405010900.CAA19069@net.bio.net>
NNTP-Posting-Host: net.bio.net


Four important items follow: How to cancel e-mail subscriptions to
BIOSCI newsgroups, BIOSCI archive searching, the BIOSCI FAQ, and the
BIOSCI User Address Directory form.  If you have not yet listed
yourself in our BIOSCI user directory, please take a few minutes to
complete and return the form below.  If your personal information has
changed since you listed yourself, please send us an updated form.

				Sincerely,

				Dave Kristofferson
				BIOSCI/bionet Manager

				biosci-help@net.bio.net



	 **** How to cancel a BIOSCI e-mail subscription ****

If you want to cancel your e-mail subscription to this group, PLEASE
DO NOT POST YOUR UNSUBSCRIBE REQUEST TO THE NEWSGROUP ADDRESS (NOR
REPLY TO A MESSAGE POSTED TO THE NEWSGROUP)!!!  This would send your
request to all of the readers of the newsgroup, but it might still not
be seen by the BIOSCI staff - thus you would annoy many people and
possibly not accomplish your goal anyway.

IF YOU ARE LOCATED IN THE AMERICAS OR PACIFIC RIM COUNTRIES, please
send a message to

biosci@net.bio.net

Instructions will be returned automatically, so the contents of your
message do not matter.

IF YOU ARE LOCATED IN EUROPE, AFRICA OR CENTRAL ASIA, please send a
message to

biosci@daresbury.ac.uk

listing the name(s) of the newsgroup(s) from which you wish to be
removed.  Your message will be read by a person at that address, so no
special syntax is needed.


		 **** SEARCHING BIOSCI ARCHIVES ****

The easiest way to search the BIOSCI archives is to use gopher
software and connect over the Internet to net.bio.net, the U.S. BIOSCI
computer.  We maintain three indexes which are searchable from the
main gopher menu on net.bio.net: (1) an index of all BIOSCI postings;
(2) an index of individual journal article references from the Table
of Contents postings on the BIO-JOURNALS newsgroup; and (3) an index
of BIOSCI users including regular mail and e-mail addresses, phone/FAX
numbers, research interests, and newsgroup participation.

E-mail users can search the BIOSCI archives by using our waismail
e-mail server.  For instructions send the message

help

to waismail@net.bio.net.  Leave the Subject: line blank (anything
entered on the Subject: line is ignored).

WAIS software can also be used to search the archives as described in
the BIOSCI FAQ (see below).


       **** BIOSCI FREQUENTLY ASKED QUESTIONS (FAQ) SHEET ****

New users of BIOSCI/bionet may want to read the "Frequently Asked
Questions" or "FAQ" sheet for BIOSCI.  The FAQ provides details on how
to participate in these forums and is available for anonymous FTP from
net.bio.net [134.172.2.69] in pub/BIOSCI/doc/biosci.FAQ or for
retrieval by gopher to net.bio.net, port 70.  It may also be requested
by sending e-mail to biosci-help@net.bio.net (use plain English for
your request).  The FAQ is also posted on the first of each month to
the newsgroup